UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM

10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended ~~June 30, 2021~~March 31, 2022

or

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from

to

.

Commission File Number:

001-34791

Magnachip Semiconductor Corporation

(Exact name of registrant as specified in its charter)


Delaware		83-0406195
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

c/o MagnaChip Semiconductor ~~S.A~~.S.A.

1, Allée Scheffer,

L-2520

Luxembourg, Grand Duchy of Luxembourg

(352)

45-62-62

(Address, zip code, and telephone number, including area code, of registrant’s principal executive offices)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	MX	New York Stock Exchange
Preferred Stock Purchase Rights		New York Stock Exchange

Indicate

by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒

Yes

☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation

S-T

(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

☒

Yes

☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a

non-accelerated

filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule

12b-2

of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule

12b-2

of the Exchange Act). ☐ Yes ☒ No

As of ~~July 31, 2021,~~April 30, 2022, the registrant had ~~46,451,323~~44,894,385 shares of common stock

outstanding.

PART I—FINANCIAL INFORMATION

Item 1.

Interim Consolidated Financial Statements (Unaudited)

~~MAGNACHIP SEMICONDUCTOR CORPORATION AND SUBSIDIARIES~~

~~CONSOLIDATED BALANCE SHEETS (Unaudited)~~

June 30,
2021

December 31,
2020


(In thousands of U.S. dollars,
except share data)

Assets

Current assets

Cash and cash equivalents
   $ 271,880 $ 279,940
Accounts receivable, net
   56,730 64,390
Inventories, net
   41,369 39,039
Other receivables
   9,173 4,338
Prepaid expenses
   6,836 7,332
Hedge collateral (Note 9)
   4,830 5,250
Other current assets (Notes 10 and 19)
   5,117 9,321


Total current assets
   395,935 409,610
Property, plant and equipment, net
   94,721 96,383
Operating lease
right-of-use
assets
   4,520 4,632
Intangible assets, net
   2,541 2,727
Long-term prepaid expenses
   5,626 4,058
Deferred income taxes
   43,069 44,541
Other
non-current
assets
   11,141 9,739


Total assets
   $ 557,553 $ 571,690


Liabilities and Stockholders’ Equity

Current liabilities

Accounts payable
   $ 52,040 $ 52,164
Other accounts payable
   9,119 2,531
Accrued expenses (Note 8)
   13,020 16,241
Accrued income taxes
   1,679 12,398
Operating lease liabilities
   2,181 2,210
Current portion of long-term borrowings, net
   —   83,479
Other current liabilities (Note 10)
   5,001 4,595


Total current liabilities
   83,040 173,618
Accrued severance benefits, net
   39,520 40,462
Non-current
operating lease liabilities
   2,338 2,422
Other
non-current
liabilities
   10,024 9,588


Total liabilities
   134,922 226,090


Commitments and contingencies (Note 19)
   0 0
Stockholders’ equity

Common stock, $0.01 par value, 150,000,000 shares authorized, 55,562,907 shares issued and 46,350,945 outstanding at June 30, 2021 and 44,943,854 shares issued and 35,783,347 outstanding at December 31, 2020
   556 450
Additional
paid-in
capital
   253,244 163,010
Retained earnings
   279,163 286,834
Treasury stock, 9,211,962 shares at June 30, 2021 and 9,160,507 shares at December 31, 2020, respectively
   (109,407 ) (108,397 )
Accumulated other comprehensive income (loss)
   (925 ) 3,703


Total stockholders’ equity
   422,631 345,600


Total liabilities and stockholders’ equity
   $ 557,553 $ 571,690

~~The accompanying notes are an integral part of these consolidated financial statements.~~

3

MAGNACHIP SEMICONDUCTOR CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF ~~CASH FLOWS~~OPERATIONS (Unaudited)

Six Months Ended


June 30,
2021

June 30,
2020


(In thousands of U.S. dollars)

Cash flows from operating activities

Net income (loss)
   $ (7,671 ) $ 5,422
Adjustments to reconcile net income (loss) to net cash provided by operating activities

Depreciation and amortization
   6,998 10,479
Provision for severance benefits
   3,507 10,179
Amortization of debt issuance costs and original issue discount
   261 1,205
Loss on foreign currency, net
   13,353 26,397
Restructuring and other charges
   3,295 141
Provision for inventory reserves
   3,346 2,033
Stock-based compensation
   4,051 2,528
Other, net
   266 (111 )
Changes in operating assets and liabilities

Accounts receivable, net
   5,098 (438 )
Unbilled accounts receivable, net
   —   10,933
Inventories
   (7,170 ) (14,060 )
Other receivables
   (4,841 ) 67
Other current assets
   8,623 4,747
Accounts payable
   1,040 4,947
Other accounts payable
   (2,287 ) (5,898 )
Accrued expenses
   (3,980 ) 161
Accrued income taxes
   (10,249 ) 349
Other current liabilities
   (102 ) 871
Other
non-current
liabilities
   (274 ) 1,238
Payment of severance benefits
   (2,836 ) (4,272 )
Other, net
   (62 ) 147


Net cash provided by operating activities
   10,366 57,065
Cash flows from investing activities

Proceeds from settlement of hedge collateral
   972 5,855
Payment of hedge collateral
   (585 ) (7,841 )
Purchase of property, plant and equipment
   (4,866 ) (8,842 )
Payment for intellectual property registration
   (288 ) (473 )
Collection of guarantee deposits
   307 47
Payment of guarantee deposits
   (4,960 ) (571 )
Other, net
   (130 ) 21


Net cash used in investing activities
   (9,550 ) (11,804 )
Cash flows from financing activities

Proceeds from exercise of stock options
   2,549 663
Acquisition of treasury stock
   (1,653 ) (1,021 )
Repayment of financing related to water treatment facility arrangement
   (288 ) (267 )
Repayment of principal portion of finance lease liabilities
   (33 ) (119 )


Net cash provided by (used in) financing activities
   575 (744 )
Effect of exchange rates on cash and cash equivalents
   (9,451 ) (3,350 )


Net increase (decrease) in cash and cash equivalents
   (8,060 ) 41,167
Cash and cash equivalents

Beginning of the period
   279,940 151,657


End of the period
   $ 271,880 $ 192,824


Supplemental cash flow information

Cash paid for interest
   $ 2,094 $ 9,522
Cash paid for income taxes
   $ 11,227 $ 1,889
Non-cash
investing activities

Property, plant and equipment additions in other accounts payable
   $ 3,632 $ 602
Non-cash
financing activities

Exchange of exchangeable senior notes into common stock
   $ 83,740 $ —


	Three Months Ended
	March 31, 2022			March 31, 2021
	(In thousands of U.S. dollars, except share data)
Revenues:

Net sales – standard products business	$	94,010		$	112,906
Net sales – transitional Fab 3 foundry services		10,083			10,113

Total revenues		104,093			123,019
Cost of sales:
Cost of sales – standard products business		56,080			79,247
Cost of sales – transitional Fab 3 foundry services		9,017			9,390

Total cost of sales		65,097			88,637

Gross profit		38,996			34,382
Operating expenses:
Selling, general and administrative expenses		14,163			12,634
Research and development expenses		11,954			13,423
Merger-related costs		—			9,831
Other charges		—			585

Total operating expenses		26,117			36,473

Operating income (loss)		12,879			(2,091	)
Interest expense		(111	)		(1,041	)
Foreign currency loss, net		(690	)		(4,671	)
Other income, net		933			620

Income (loss) before income tax expense		13,011			(7,183	)
Income tax expense		3,483			290

Net income (loss)	$	9,528		$	(7,473	)

Basic earnings (loss) per common share—	$	0.21		$	(0.19	)
Diluted earnings (loss) per common share—	$	0.20		$	(0.19	)
Weighted average number of shares—
Basic		45,603,208			40,292,838
Diluted		46,693,294			40,292,838

The accompanying notes are an integral part of these consolidated financial statements.

7

4

MAGNACHIP SEMICONDUCTOR CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (Unaudited)


	Three Months Ended
	March 31, 2022			March 31, 2021
	(In thousands of US dollars)

Net income (loss)	$	9,528		$	(7,473	)
Other comprehensive loss
Foreign currency translation adjustments		(3,045	)		(2,058	)
Derivative adjustments
Fair valuation of derivatives		(1,264	)		(2,125	)
Reclassification adjustment for loss (gain) on derivatives included in net income (loss)		762			(511	)

Total other comprehensive loss		(3,547	)		(4,694	)

Total comprehensive income (loss)	$	5,981		$	(12,167	)

The accompanying notes are an integral part of these consolidated financial statements.

5

MAGNACHIP SEMICONDUCTOR CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (Unaudited)


						Additional Paid-In Capital									Accumulated Other Comprehensive Income (Loss)
	Common Stock								Retained Earnings			Treasury Stock						Total
(In thousands of U.S. dollars, except share data)	Shares			Amount					Retained Earnings			Treasury Stock						Total
Three Months Ended March 31, 2022:

Balance at December 31, 2021		45,659,304		$	559	$	241,197		$	343,542		$	(130,306	)	$	(2,230	)	$	452,762
Stock-based compensation		—			—		1,638			—			—			—			1,638
Exercise of stock options		151,326			1		1,780			—			—			—			1,781
Settlement of restricted stock units		168,795			2		(2	)		—			—			—			—
Acquisition of treasury stock		(53,464	)		—		0			—			(1,000	)		—			(1,000	)
Accelerated stock repurchase		(1,031,576	)		—		17,217			—			(17,217	)		—			—
Other comprehensive loss, net		—			—		—			—			—			(3,547	)		(3,547	)
Net income		—			—		—			9,528			—			—			9,528

Balance at March 31, 2022		44,894,385		$	562	$	261,830		$	353,070		$	(148,523	)	$	(5,777	)	$	461,162

Three Months Ended March 31, 2021:
Balance at December 31, 2020		35,783,347		$	450	$	163,010		$	286,834		$	(108,397	)	$	3,703		$	345,600
Stock-based compensation		—			—		1,646			—			—			—			1,646
Exchange of exchangeable senior notes		10,144,131			101		83,639			—			—			—			83,740
Exercise of stock options		175,760			2		2,536			—			—			—			2,538
Settlement of restricted stock units		205,630			2		(2	)		—			—			—			—
Acquisition of treasury stock		(51,455	)		—		—			—			(1,010	)		—			(1,010	)
Other comprehensive loss, net		—			—		—			—			—			(4,694	)		(4,694	)
Net loss		—			—		—			(7,473	)		—			—			(7,473	)

Balance at March 31, 2021		46,257,413		$	555	$	250,829		$	279,361		$	(109,407	)	$	(991	)	$	420,347

The accompanying notes are an integral part of these consolidated financial statements.

6

MAGNACHIP SEMICONDUCTOR CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)


	Three Months Ended
	March 31, 2022			March 31, 2021
	(In thousands of U.S. dollars)
Cash flows from operating activities

Net income (loss)	$	9,528		$	(7,473	)
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Depreciation and amortization		3,891			3,448
Provision for severance benefits		1,670			1,771
Amortization of debt issuance costs and original issue discount		—			261
Loss on foreign currency, net		6,380			14,873
Provision for inventory reserves		145			1,504
Stock-based compensation		1,638			1,646
Other, net		161			154
Changes in operating assets and liabilities
Accounts receivable, net		(1,213	)		9,794
Inventories		1,456			6,071
Other receivables		667			(1,438	)
Other current assets		(6,829	)		5,427
Accounts payable		538			(7,701	)
Other accounts payable		(702	)		1,570
Accrued expenses		187			2,393
Accrued income taxes		(2,346	)		(10,700	)
Other current liabilities		(711	)		1,087
Other non-current liabilities		(73	)		18
Payment of severance benefits		(1,389	)		(1,493	)
Other, net		(178	)		12

Net cash provided by operating activities		12,820			21,224
Cash flows from investing activities
Proceeds from settlement of hedge collateral		1,829			—
Payment of hedge collateral		(2,891	)		—
Purchase of property, plant and equipment		(944	)		(1,082	)
Payment for intellectual property registration		(59	)		(171	)
Other, net		(77	)		(111	)

Net cash used in investing activities		(2,142	)		(1,364	)
Cash flows from financing activities
Proceeds from exercise of stock options		1,781			2,538
Acquisition of treasury stock		(830	)		(1,540	)
Repayment of financing related to water treatment facility arrangement		(134	)		(144	)
Repayment of principal portion of finance lease liabilities		(16	)		(16	)

Net cash used in financing activities		801			838
Effect of exchange rates on cash and cash equivalents		(6,105	)		(10,444	)

Net increase in cash and cash equivalents		5,374			10,254
Cash and cash equivalents at beginning of period		279,547			279,940

Cash and cash equivalents at end of period	$	284,921		$	290,194

Supplemental cash flow information
Cash paid for interest	$	—		$	2,094
Cash paid for income taxes	$	5,421		$	9,633
Non-cash investing activities
Property, plant and equipment additions in other accounts payable	$	524		$	622
Non-cash financing activities
Exchange of exchangeable senior notes into common stock	$	—		$	83,740
Acquisition of treasury stock to satisfy the tax withholding obligations in connection with equity-based compensation	$	(996	)	$	(114	)

The accompanying notes are an integral part of these consolidated financial statements.

7

MAGNACHIP SEMICONDUCTOR CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(TABULAR DOLLARS IN THOUSANDS, EXCEPT SHARE DATA)

1. Business, Basis of Presentation and Significant Accounting Policies

Business

Magnachip Semiconductor Corporation (together with its subsidiaries, the “Company”) is a designer and manufacturer of analog and mixed-signal semiconductor platform solutions for communications, Internet of Things (“IoT”) applications, consumer, computing, industrial and automotive applications. ~~The Company provides technology platforms for analog, mixed signal, power, high voltage,~~

~~non-volatile~~

~~memory and Radio Frequency (“RF”) applications.~~

On September 1, 2020 (the “Closing Date”), the Company completed the sale of the Company’s Foundry Services Group business and its fabrication facility located in Cheongju, Korea, known as “Fab 4” to Key Foundry Co., Ltd. (the “Buyer”), a Korean corporation, in exchange for a purchase price equal to approximately $350.6 million in cash, pursuant to the terms of a business transfer agreement (the “Business Transfer Agreement”) dated March 31, 2020 by and among the Company and Magnus Semiconductor, LLC, a Korean limited liability company (“Magnus”). The purchase price was paid in a combination of U.S. Dollars in the amount of $46.5 million and Korean Won in the amount of approximately KRW 360.6 billion. In addition to the purchase price, the Buyer assumed all severance liabilities relating to the transferred employees, which had a value of approximately $100 million. The Buyer is a wholly owned subsidiary of Magnus, which was established by Alchemist Capital Partners Korea Co., Ltd. and Credian Partners, Inc. On April 20, 2020, Magnus assigned, and the Buyer assumed, all rights and obligations of Magnus under the Business Transfer Agreement. This divestiture of the Foundry Services Group business and Fab 4 was made in connection with the Company’s strategic shift of its operational focus to its standard products business. The Foundry Services Group was historically a reportable segment. The Foundry Services Group business was classified as discontinued operations in the Company’s consolidated statements of operations and excluded from both continuing operations and segment results for the three months ended March 31, 2020. Accordingly, the Company has one reportable segment, its standard products business, together with transitional foundry services associated with its fabrication facility located in Gumi, Korea, known as “Fab 3,” that it expects to perform for the Buyer for a period of up to three years from the Closing Date (the “Transitional Fab 3 Foundry Services”).

The Company’s standard products business includes its Display Solutions and Power Solutions business lines. The Company’s Display Solutions products provide panel display solutions to major suppliers of large and small rigid and flexible panel displays, and mobile, automotive applications and home appliances. The Company’s Power Solutions products include discrete and integrated circuit solutions for power management in communications, consumer, computing, servers, automotive, and industrial applications.

On September 1, 2020, the Company completed the sale of the Company’s Foundry Services Group business and its fabrication facility located in Cheongju, Korea, known as “Fab 4”. Following the consummation of the sale, and for up to three years, the Company is expected to provide transitional foundry services associated with its fabrication facility located in Gumi, Korea, known as “Fab 3, at an agreed upon cost plus

mark-up

(the “Transitional Fab 3 Foundry Services”).

Basis of Presentation

The accompanying unaudited interim consolidated financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). These interim consolidated financial statements include normal recurring adjustments and the elimination of all intercompany accounts and transactions which are, in the opinion of management, necessary to provide a fair statement of the Company’s financial condition and results of operations for the periods presented. These interim consolidated financial statements are presented in accordance with Accounting Standards Codification (“ASC”) 270, “Interim Reporting” and, accordingly, do not include all of the information and note disclosures required by U.S. GAAP for complete financial statements, except for the changes below. The results of operations for the three ~~and six~~ months ended ~~June 30, 2021~~March 31, 2022 are not necessarily indicative of the results to be expected for a full year or for any other periods. The consolidated statement of cash flow for the six months ended June 30, 2020 has not been adjusted to separately disclose the cash flow related to discontinued operations, but the material items in the operating and investing activities of the cash flow relating to discontinued operations for the same period is disclosed in Note 3. Unless otherwise stated, information in these notes to consolidated financial statements relates to the Company’s continuing operations and excludes the discontinued operations.

The December 31, ~~2020~~2021 balance sheet data was derived from the Company’s audited financial statements, but does not include all disclosures required by U.S. GAAP. The interim consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form

10-K

for the fiscal year ended December 31, ~~2020.~~2021.

There have been no material changes to the Company’s significant accounting policies as of and for the three months ended March 31, 2022 as compared to the significant accounting policies described in the Company’s Annual Report on Form

10-K

for the fiscal year ended December 31, 2021.

Recently Adopted Accounting Pronouncements

In ~~December 2019,~~August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)

No. ~~2019-12,~~2020-06,

“~~Income Taxes (Topic 740): Simplifying~~Debt—Debt with Conversion and Other Options (Subtopic

470-20)

and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic

815-40)”

(“ASU

2020-06”),

which updates various codification topics to simplify the ~~Accounting~~accounting guidance for ~~Income Taxes” (“ASU~~

~~2019-12”).~~

~~ASU~~

~~2019-12~~

~~removes~~ certain ~~exceptions to~~financial instruments with characteristics of liabilities and equity, with a specific focus on convertible instruments and the ~~general principles~~derivative scope exception for contracts in ~~Topic 740~~an entity’s own equity and ~~improves consistent application of and simplifies GAAP~~amends the diluted EPS computation for ~~other areas of Topic 740 by clarifying and amending existing guidance.~~these instruments. The Company adopted ASU

~~2019-12~~2020-06

as of January 1, ~~2021,~~2022, and the adoption of ASU

~~2019-12~~2020-06

did not have ~~a material~~an impact on the Company’s consolidated financial statements.

In May 2021, the FASB issued ASU

No. 2021-04,

“Earnings Per Share (Topic 260), Debt-Modifications and Extinguishments (Subtopic

470-50)”,

Compensation-Stock Compensation (Topic 718), and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic

815-40):

Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity-Classified Written Call Options” (“ASU

2021-04”),

ASU

2021-04

clarifies the accounting for modifications or exchanges of freestanding equity-classified written call options so that the transaction should be treated as an exchange of the original instrument for a new instrument. The Company adopted ASU

2021-04

as of January 1, 2022, and the adoption of ASU

2021-04

did not have an impact on the Company’s consolidated financial statements.

8

Table of Contents

2. ~~Merger Agreement~~Inventories

On March 25, 2021, the Company, South Dearborn Limited, an exempted company incorporated in the Cayman Islands with limited liability (“Parent”), formed by an affiliate of Wise Road Capital LTD, and Michigan Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), entered into an Agreement and Plan of Merger (the “Merger Agreement”). The Merger Agreement provides that, among other things, and subject to the terms and conditions thereof, Merger Sub will be merged with and into the Company (the “Merger”), with the Company continuing its corporate existence under the General Corporation Law of the State of Delaware (the “DGCL”) as the surviving corporation in the Merger and becoming a wholly owned subsidiary of Parent.

Pursuant to the Merger Agreement, each share of the Company’s common stock, par value $0.01 per share (the “Common Stock”), issued and outstanding immediately before the effective time of the Merger (the “Effective Time”) (other than (a) shares of Common Stock owned by the Company or any of its wholly owned subsidiaries or by Parent or any of its subsidiaries immediately before the Effective Time (collectively,

~~the~~

“Excluded Shares”) and (b) any shares of Common Stock for which the holder thereof (i) has not voted in favor of the Merger or consented to it in writing and (ii) has properly and validly exercised their statutory rights of appraisal in respect of such shares of Common Stock in accordance with Section 262 of the DGCL (collectively, “Dissenting Shares”)) will be cancelled and will cease to exist and will be automatically converted into the right to receive $29.00 in cash, without interest (the “Merger Consideration”), subject to applicable withholding taxes.

Consummation of the Merger is subject to certain customary closing conditions, including (i) approval of the Merger Agreement by our stockholders, (ii) the receipt of certain required or requested governmental approvals or authorizations (including from the Committee on Foreign Investment in the United States (“CFIUS”) and the Korean Ministry of Trade, Industry and Energy (“MOTIE”)), (iii) the absence of any order or law issued, enacted or deemed applicable by certain governmental authorities specified in the Merger Agreement that makes consummation of the Merger illegal and that remains in effect (a “Prohibitive Order”), (iv) the absence of a Company Material Adverse Effect (as defined in the Merger Agreement) and (v) other customary closing conditions, including the accuracy of each party’s representations and warranties, and each party’s compliance with its obligations under the Merger Agreement (subject in the case of this clause (v) to certain materiality qualifiers).

The Merger Agreement contains termination rights for each of the Company and Parent, including if (i) the consummation of the Merger does not occur by 11:59 p.m. (New York time) on September 25, 2021 (subject to extension to December 25, 2021 and again to March 25, 2022 at the option of either party if certain regulatory approvals or authorizations have not been obtained by such date or certain governmental authorities specified in the Merger Agreement have issued, enacted or deemed applicable a Prohibitive Order), (ii) the Requisite Company Vote is not obtained, (iii) any of certain governmental authorities specified in the Merger Agreement issues, enacts or deems applicable after the date of the Merger Agreement a Prohibitive Order that has become final and

~~non-appealable,~~

~~or (iv) the other party has breached the Merger Agreement, which breach would give rise to a failure, or has materially contributed to the failure, of certain conditions to the~~

~~non-breaching~~

~~party’s obligations to close (subject to a cure period). Additionally, each of the Company and Parent may terminate the Merger Agreement in certain other circumstances.~~

~~For the three and six months ended June 30, 2021, the Company incurred $2,459 thousand and $12,290 thousand, respectively, of professional fees and certain transaction~~

~~related-expenses~~

~~incurred in connection with the Merger, which were recognized in other charges in the consolidated statements of operations.~~

The foregoing description of the Merger Agreement is not complete and is qualified in its entirety by reference to the Merger Agreement, which is filed as Exhibit 2.1 to the Company’s Current Report on Form

~~8-K~~

~~filed on March 29, 2021.~~

9

~~Table of Contents~~

~~3. Discontinued Operations~~

On September 1, 2020, the Company completed the sale of the Company’s Foundry Services Group business and Fab 4. As a result of the sale of the Foundry Services Group business and Fab 4, the Company recorded a gain of $287,117

thousand and all operations from the Foundry Services Group business and Fab 4 were classified as discontinued operations for the three and six months ended June 30, 2020. Following the consummation of the sale, and for up to three years, the Company is expected to provide the Transitional Fab 3 Foundry Services at an agreed upon cost plus

~~mark-up.~~

For the periods prior to the Closing Date, revenue from providing the Transitional Fab 3 Foundry Services to the Foundry Services Group is recorded at cost on both of the continuing and discontinued businesses for comparative purposes. Cash inflows to the Company from the Buyer related to providing the Transitional Fab 3 Foundry Services were

~~$11,166 thousand and $24,790 thousand for the three and six months ended June 30, 2021, respectively.~~

~~The following table summarizes the results from discontinued operations, net of tax, for the three and six months ended June 30, 2020.~~

Three Months Ended

Six Months Ended


June 30,
2020

June 30,
2020


(In thousands of U.S. dollars)

Revenues:

Net sales – Foundry Services Group
   $ 95,779    $ 182,058
Net sales – transitional Fab 3 foundry services
   (9,873 )    (19,610 )




Total revenues
   85,906    162,448
Cost of sales:

Cost of sales – Foundry Services Group
   64,869    130,452
Cost of sales – transitional Fab 3 foundry services
   (9,873 )    (19,610 )




Total cost of sales
   54,996    110,842




Gross profit
   30,910    51,606
Operating expenses:

Selling, general and administrative expenses
   4,992    10,636
Research and development expenses
   6,915    14,318
Restructuring and other charges
   589    2,704




Total operating expenses
   12,496    27,658




Operating income from discontinued operations
   18,414    23,948
Foreign currency gain (loss), net
   (23 )    2,074
Others, net
   (59 )    48




Income from discontinued operations before income tax expense
   18,332    26,070
Income tax expense
   935    1,344




Income from discontinued operations, net of tax
   $ 17,397    $ 24,726

~~For the three and six months ended June 30, 2020, the Company recorded $589 thousand and $2,704~~

thousand, respectively, in professional fees incurred in connection with the sale of the Foundry Services Group business and Fab 4, and recorded such costs as restructuring and other charges in the abov

e

.

~~The following table provides supplemental cash flows information related to discontinued operations:~~

Six Months Ended


June 30,
2020


(In thousands of U.S. dollars)

Significant
non-cash
operating activities:

Depreciation and amortization
   $ 5,365
Provision for severance benefits
   6,405
Stock-based compensation
   263
Investing activities:

Capital expenditures
   $ (4,415 )

10

~~Table of Contents~~

~~4. Inventories~~

Inventories as of ~~June 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 consist of the following (in thousands):

June 30,
2021

December 31,
2020

Finished goods
   $ 7,829    $ 6,425
Semi-finished goods and
work-in-process
   32,524    30,968
Raw materials
   8,524    6,526
Materials
in-transit
   593    1,021
Less: inventory reserve
   (8,101 )    (5,901 )




Inventories, net
   $ 41,369    $ 39,039


	March 31, 2022			December 31, 2021

Finished goods	$	5,591		$	9,594
Semi-finished goods and work-in-process		25,119			25,968
Raw materials		9,839			9,443
Materials in-transit		1,953			95
Less: inventory reserve		(5,555	)		(5,730	)

Inventories, net	$	36,947		$	39,370

Changes in inventory reserve for the three ~~and six~~ months ended ~~June 30,~~March 31, 2022 and 2021 ~~and 2020~~ are as follows (in thousands):

Three Months
Ended

Six Months
Ended

Three Months
Ended

Six Months
Ended


June 30, 2021

June 30, 2020

Beginning balance
   $ (6,281 )    $ (5,901 )    $ (4,807 )    $ (5,947 )
Change in reserve

Inventory reserve charged to costs of sales
   (3,186 )    (5,350 )    (1,794 )    (3,069 )
Sale of previously reserved inventory
   1,343    1,977    747    1,653








   (1,843 )    (3,373 )    (1,047 )    (1,416 )
Write off
   28    930    642    1,141
Translation adjustments
   (5 )    243    (95 )    221
Reclassified to assets held for sale
   —      —      —      694








Ending balance
   $ (8,101 )    $ (8,101 )    $ (5,307 )    $ (5,307 )


	Three Months Ended
	March 31, 2022			March 31, 2021

Beginning balance	$	(5,730	)	$	(5,901	)
Change in reserve
Inventory reserve charged to costs of sales		(1,607	)		(2,164	)
Sale of previously reserved inventory		1,452			634

		(155	)		(1,530	)
Write off		211			902
Translation adjustments		119			248

Ending balance	$	(5,555	)	$	(6,281	)

Inventory reserve represents the Company’s best estimate in value lost due to excessive inventory level, physical deterioration, obsolescence, changes in price levels, or other causes based on individual facts and circumstances. Inventory reserve relates to inventory items including finished goods, semi-finished goods,

work-in-process

and raw materials. Write off of this reserve is recognized only when the related inventory has been disposed or scrapped.

~~scrapped.~~

9

Table of Contents

3. Property, Plant and Equipment

Property, plant and equipment as of March 31, 2022 and December 31, 2021 are comprised of the following (in thousands):


	March 31, 2022			December 31, 2021

Buildings and related structures	$	24,003		$	24,273
Machinery and equipment		103,386			105,300
Finance lease right-of-use assets		309			316
Others		32,682			32,396

		160,380			162,285
Less: accumulated depreciation		(95,839	)		(94,119	)
Land		13,608			13,898
Construction in progress		24,526			25,818

Property, plant and equipment, net	$	102,675		$	107,882

Aggregate depreciation expenses totaled $3,706 thousand and $3,262 thousand for the three months ended March 31, 2022 and 2021, respectively.

114. Intangible Assets

Intangible assets as of March 31, 2022 and December 31, 2021 are comprised of the following (in thousands):


	March 31, 2022
	Gross amount		Accumulated amortization			Net amount

Intellectual property assets	$	9,180	$	(6,977	)	$	2,203

Intangible assets	$	9,180	$	(6,977	)	$	2,203


	December 31, 2021
	Gross amount		Accumulated amortization			Net amount

Intellectual property assets	$	9,312	$	(6,935	)	$	2,377

Intangible assets	$	9,312	$	(6,935	)	$	2,377

Aggregate amortization expenses for intangible assets totaled $185 thousand and $186 thousand for the three months ended March 31, 2022 and 2021, respectively.

10

Table of Contents

5. ~~Property, Plant and Equipment~~

~~Property, plant and equipment as of June 30, 2021 and December 31, 2020 are comprised of the following (in thousands):~~

June 30,
2021

December 31,
2020

Buildings and related structures
   $ 24,184    $ 24,882
Machinery and equipment
   104,875    106,244
Finance lease
right-of-use
assets
   331    344
Others
   44,277    40,116




   173,667    171,586
Less: accumulated depreciation
   (93,549 )    (90,370 )
Land
   14,603    15,167




Property, plant and equipment, net
   $ 94,721    $ 96,383

~~Aggregate depreciation expenses totaled $6,626 thousand and $4,794 thousand for the six months ended June 30, 2021 and 2020, respectively.~~

~~6. Intangible Assets~~

~~Intangible assets as of June 30, 2021 and December 31, 2020 are comprised of the following (in thousands):~~

June 30, 2021


Gross
amount

Accumulated
amortization

Net
amount

Intellectual property assets
   $ 9,425    $ (6,884 )    $ 2,541






Intangible assets
   $ 9,425    $ (6,884 )    $ 2,541

December 31, 2020


Gross
amount

Accumulated
amortization

Net
amount

Intellectual property assets
   $ 9,486    $ (6,759 )    $ 2,727






Intangible assets
   $ 9,486    $ (6,759 )    $ 2,727

~~Aggregate amortization expenses for intangible assets totaled $372 thousand and $320~~

~~thousand for the six months ended June 30, 2021 and 2020,~~

~~respectively.~~

12

~~Table of Contents~~

7. Leases

The Company has operating and finance leases for buildings and other assets such as vehicles and office equipment. The Company’s leases have remaining lease terms ranging from 1 year to 54 years.

The tables below present financial information related to the Company’s leases.

Supplemental balance sheets information related to leases as of ~~June 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 are as follows (in thousands):

Leases

Classification

June 30,
2021

December 31,
2020

Assets

Operating lease

Operating lease right-of-use assets
   $ 4,520    $ 4,632
Finance lease

Property, plant and equipment, net
   165    206




Total lease assets
      $ 4,685    $ 4,838




Liabilities

Current

Operating

Operating lease liabilities
   $ 2,181    $ 2,210
Finance

Other current liabilities
   69    68
Non-current

Operating

Non-current
operating lease liabilities
   2,338    2,422
Finance

Other
non-current
liabilities
   112    153




Total lease liabilities
      $ 4,700    $ 4,853


Leases	Classification	March 31, 2022		December 31, 2021
Assets

Operating lease	Operating lease right-of-use assets	$	3,719	$	4,275
Finance lease	Property, plant and equipment, net		108		126

Total lease assets		$	3,827	$	4,401

Liabilities
Current
Operating	Operating lease liabilities	$	2,223	$	2,323
Finance	Other current liabilities		67		68
Non-current
Operating	Non-current operating lease liabilities		1,496		1,952
Finance	Other non-current liabilities		54		73

Total lease liabilities		$	3,840	$	4,416

The following table presents the weighted average remaining lease term and discount rate:

June 30,
2021

December 31,
2020

Weighted average remaining lease term

Operating leases
   2.9 years 3.0 years
Finance leases
   2.5 years 3.0 years
Weighted average discount rate

Operating leases
   4.71 % 5.55 %
Finance leases
   7.75 % 7.75 %


	March 31, 2022			December 31, 2021

Weighted average remaining lease term

Operating leases		2.3 years			2.4 years
Finance leases		1.8 years			2.0 years
Weighted average discount rate
Operating leases		4.12	%		4.20	%
Finance leases		7.75	%		7.75	%

The components of lease cost included in the Company’s consolidated statements of operations, are as follows (in thousands):

Three Months Ended

Six Months Ended


June 30,
2021

June 30,
2020

June 30,
2021

June 30,
2020

Operating lease cost
   $ 727    $ 461    $ 1,407    $ 929
Finance lease cost

Amortization of
right-of-use
assets
   16    15    33    31
Interest on lease liabilities
   3    4    7    9








Total lease cost
   $ 746    $ 480    $ 1,447    $ 969


	Three Months Ended
	March 31, 2022		March 31, 2021



Operating lease cost	$	569	$	680
Finance lease cost
Amortization of right-of-use assets		16		17
Interest on lease liabilities		2		4

Total lease cost	$	587	$	701

The above table does not include an immaterial cost of short-term leases for the three ~~and six~~ months ended ~~June 30, 2021~~March 31, 2022 and ~~2020.~~2021.

11

13

Table of Contents

Other lease information is as follows (in thousands):

Three Months Ended

Six Months Ended


June 30,
2021

June 30,
2020

June 30,
2021

June 30,
2020

Cash paid for amounts included in the measurement of lease liabilities

Operating cash flows from operating leases
   $ 727    $ 461    $ 1,407    $ 929
Operating cash flows from finance leases
   3    4    7    9
Financing cash flows from finance leases
   17    14    33    28


	Three Months Ended
	March 31, 2022		March 31, 2021
Cash paid for amounts included in the measurement of lease liabilities

Operating cash flows from operating leases	$	569	$	680
Operating cash flows from finance leases		2		4
Financing cash flows from finance leases		16		16

The aggregate future lease payments for operating and finance leases as of ~~June 30, 2021~~March 31, 2022 are as follows (in thousands):

Operating
Leases

Finance
Leases

Remainder of 2021
   $ 1,409    $ 40
2022
   1,574    79
2023
   837    80
2024
   601    0
2025
   414    0




Total future lease payments
   4,835    199
Less: Imputed interest
   (316 )    (18 )




Present value of future payments
   $ 4,519    $ 181


	Operating Leases			Finance Leases

Remainder of 2022	$	1,837		$	56
2023		1,079			74
2024		607			0
2025		393			0

Total future lease payments		3,916			130
Less: Imputed interest		(197	)		(9	)

Present value of future payments	$	3,719		$	121

8.6. Accrued Expenses

Accrued expenses as of ~~June 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 are comprised of the following (in thousands):

June 30,
2021

December 31,
2020

Payroll, benefits and related taxes, excluding severance benefits
   $ 8,259    $ 10,296
Withholding tax attributable to intercompany interest income
   1,144    28
Interest on senior notes
   —      1,396
Outside service fees
   1,179    755
Restructuring and others
   1,611    2,658
Others
   827    1,108




Accrued expenses
   $ 13,020    $ 16,241


	March 31, 2022		December 31, 2021

Payroll, benefits and related taxes, excluding severance benefits	$	8,854	$	9,548
Withholding tax attributable to intercompany interest income		2,405		1,950
Outside service fees		1,829		1,088
Merger-related costs		6,325		7,035
Others		1,160		450

Accrued expenses	$	20,573	$	20,071

1

4

2

9.7. Derivative Financial Instruments

The Company’s Korean subsidiary from time to time has entered into zero cost collar contracts to hedge the risk of changes in the functional-currency-equivalent cash flows attributable to currency rate changes on U.S. dollar denominated revenues.

Details of the zero cost collar contracts as of ~~June 30, 2021~~March 31, 2022 are as follows (in thousands):

Date of transaction

Total notional amount

Month of settlement
December 15, 2020
   $ 30,000    July 2021 to December 2021
February 26, 2021
   $ 18,000    July 2021 to December 2021
May 13, 2021
   $ 39,000    January 2022 to September 2022


Date of transaction	Total notional amount		Month of settlement


May 13, 2021	$	24,000	April 2022 to September 2022
August 13, 2021	$	39,000	April 2022 to December 2022
January 04, 2022	$	39,000	October 2022 to June 2023
March 07, 2022	$	24,000	July 2023 to December 2023

Details of the zero cost collar contracts as of December 31, ~~2020~~2021 are as follows (in thousands):

Date of transaction

Total notional amount

Month of settlement
July 13, 2020
   $ 30,000    January 2021 to June 2021
December 15, 2020
   $ 30,000    July 2021 to December 2021
December 18, 2020
   $ 18,000    March 2021 to June 2021

The zero cost collar contracts qualify as cash flow hedges under ASC 815, “Derivatives and Hedging,” since at both the inception of the contracts and on an ongoing basis, the hedging relationship was and is expected to be highly effective in achieving offsetting cash flows attributable to the hedged risk during the term of the ~~contract~~

s

.contracts.

The fair values of the Company’s outstanding zero cost collar contracts recorded as assets and liabilities as of ~~June 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 are as follows (in thousands):

Derivatives designated as hedging instruments:

June 30,
2021

December 31,
2020

Asset Derivatives:

Zero cost collars
   Other current assets    $ —      $ 2,036
Liability Derivatives:

Zero cost collars
   Other current liabilities    $ 846    $ 195
Zero cost collars
   Other
non-current
liabilities    $ 66    $ —


Derivatives designated as hedging instruments:		March 31, 2022		December 31, 2021
Asset Derivatives:

Zero cost collars	Other non-current assets	$	94	$	0
Liability Derivatives:
Zero cost collars	Other current liabilities	$	2,421	$	2,020
Zero cost collars	Other non-current liabilities	$	149	$	0

Offsetting of derivative assets and liabilities as of March 31, 2022 is as follows (in thousands):


As of March 31, 2022	Gross amounts of recognized assets/liabilities		Gross amounts offset in the balance sheets		Net amounts of assets/liabilities presented in the balance sheets		Gross amounts not offset in the balance sheets				Net amount
As of March 31, 2022	Gross amounts of recognized assets/liabilities		Gross amounts offset in the balance sheets				Financial instruments		Cash collateral pledged		Net amount
Asset Derivatives:

Zero cost collars	$	94	$	0	$	94	$	0	$	0	$	94
Liability Derivatives:
Zero cost collars	$	2,570	$	0	$	2,570	$	0	$	(3,060)	$	(490)

Offsetting of derivative liabilities as of ~~June 30,~~December 31, 2021 is as follows (in thousands):


As of June 30, 2021	Gross amounts of recognized liabilities		Gross amounts offset in the balance sheets		Net amounts of liabilities presented in the balance sheets		Gross amounts not offset in the balance sheets				Net amount
							Financial instruments		Cash collateral pledged
As of December 31, 2021													Gross amounts of recognized liabilities		Gross amounts offset in the balance sheets		Net amounts of liabilities presented in the balance sheets		Gross amounts not offset in the balance sheets				Net amount
																			Financial instruments		Cash collateral pledged
Liability Derivatives:

Zero cost collars	$	912	$	0	$	912	$	0	$	(580)	$	332	$	2,020	$	0	$	2,020	$	0	$	(2,060)	$	(40)

~~Offsetting of derivative assets and liabilities as of December 31, 2020 is as follows (in thousands):~~

As of December 31, 2020

Gross amounts of
recognized
assets/liabilities

Gross amounts
offset in the
balance sheets

Net amounts of
assets/liabilities
presented in the
balance sheets

Gross amounts not offset
in the balance sheets

Net amount


Financial
instruments

Cash collateral
pledged

Asset Derivatives:

Zero cost collars
   $ 2,036    $ 0      $ 2,036    $ 0      $ 0      $ 2,036
Liability Derivatives:

Zero cost collars
   $ 195    $ 0      $ 195    $ 0      $ 0      $ 195

For derivative instruments that are designated and qualify as cash flow hedges, gains or losses on the derivative aside from components excluded from the assessment of effectiveness are reported as a component of accumulated other comprehensive income (“AOCI”) and reclassified into earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative, representing hedge components excluded from the assessment of effectiveness, are recognized in current earnings.

The following table summarizes the impact of derivative instruments on the consolidated statements of operations for the three months ended ~~June 30,~~March 31, 2022 and 2021 ~~and 2020. Net sales of discontinued operations for the three months ended June 30, 2020 are included in the below table~~ (in thousands):

Derivatives in ASC
815 Cash Flow Hedging
Relationships

Amount of Income
Recognized in
AOCI on
Derivatives

Location/Amount of Gain
(Loss)
Reclassified from AOCI
Into Statement of Operations

Location/Amount of Gain (Loss)
Recognized in
Statement of Operations on Derivatives


Three Months Ended
June 30,

Three Months Ended
June 30,

Three Months Ended
June 30,


2021

2020

2021

2020

2021

2020

Zero cost collars
   $ 432    $ 2,204    Net sales    $ 475    $ (193 ) Other income, net    $ (58 ) $ 55










   $ 432    $ 2,204       $ 475    $ (193 )    $ (58 ) $ 55


Derivatives in ASC 815 Cash Flow Hedging Relationships	Amount of Loss Recognized in AOCI on Derivatives						Location/Amount of Gain (Loss) Reclassified from AOCI Into Statement of Operations							Location/Amount of Loss Recognized in Statement of Operations on Derivatives
	Three Months Ended March 31,								Three Months Ended March 31,							Three Months Ended March 31,
	2022			2021					2022			2021				2022			2021

Zero cost collars	$	(1,264	)	$	(2,125	)		Net sales	$	(762	)	$	511		Other income, net	$	(129	)	$	(86)

	$	(1,264	)	$	(2,125	)			$	(762	)	$	511			$	(129	)	$	(86)

The following table summarizes the impact of derivative instruments on the consolidated statements of operations for the six months ended June 30, 2021 and 2020. Net sales of discontinued operations for the six months ended June 30, 2020 are included in the below table (in thousands):

Derivatives in ASC
815 Cash Flow Hedging
Relationships

Amount of Loss
Recognized in
AOCI on
Derivatives

Location/Amount of Gain
(Loss)
Reclassified from AOCI
Into Statement of Operations

Location/Amount of Gain (Loss)
Recognized in
Statement of Operations on Derivatives


Six Months Ended
June 30,

Six Months Ended
June 30,

Six Months Ended
June 30,


2021

2020

2021

2020

2021

2020

Zero cost collars
   $ (1,693 ) $ (2,800 ) Net sales    $ 986    $ (251 ) Other income, net    $ (144 ) $ 172








   $ (1,693 ) $ (2,800 )    $ 986    $ (251 )    $ (144 ) $ 172

As of ~~June 30, 2021,~~March 31, 2022, the amount expected to be reclassified from accumulated other comprehensive loss into loss within the next 12 months is ~~$1,045~~$1,907 thousand.

The Company set aside cash deposits to the counterparties, Nomura Financial Investment (Korea) Co., Ltd. (“NFIK”~~), Deutsche Bank AG, Seoul Branch (“DB”~~) and Standard Chartered Bank Korea Limited (“SC”), as required for the zero cost collar contracts. These cash deposits are recorded as hedge collateral on the consolidated balance sheets. Cash deposits as of ~~June 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021 are as follows (in thousands):

Counterparties

June 30,
2021

December 31,
2020

NFIK
   $ 3,250    $ 3,250
DB
   0      1,000
SC
   1,000    1,000




Total
   $ 4,250    $ 5,250


Counterparties	March 31, 2022		December 31, 2021

SC	$	1,000	$	1,000

Total	$	1,000	$	1,000

The Company is required to deposit additional cash collateral with NFIK and DBSC for any exposure in excess of $500

thousand. As of March 31, 2022, $2,360 thousand and $

~~580~~$700 thousand of additional cash collateral ~~was~~ w

as

required by NFIK and SC, respectively, and recorded as hedge collateral on the consolidated balance ~~sheets as of June 30, 2021. There was 0 such cash collateral required as~~sheet. As of December 31, ~~2020.~~2021, $760 thousand and $1,300 thousand of additional cash collateral w

as

required by NFIK and SC, respectively, and recorded as hedge collateral on the consolidated balance sheet.

These zero cost collar contracts may be terminated by the counterparties ~~in a number of circumstances, including if the Company’s credit rating falls below~~

~~B-/B3~~

or if the Company’s total cash and cash equivalents is less than $30,000 thousand at the end of a fiscal quarter, unless a waiver is obtained.

1

164

Table of Contents

~~10.~~8. Fair Value Measurements

Fair Value of Financial Instruments

~~As of June 30, 2021, the following table represents the Company’s liabilities measured at fair value on a recurring basis and the basis for that measurement (in thousands):~~

Carrying Value
June 30, 2021

Fair Value
Measurement
June 30, 2021

Quoted Prices in
Active Markets
for Identical
Liability (Level 1)

Significant
Other
Observable
Inputs
(Level 2)

Significant
Unobservable
Inputs
(Level 3)

Liabilities:

Derivative liabilities (other current liabilities)
   $ 846    $ 846    —      $ 846    —
Derivative liabilities (other
non-current
liabilities)
   $ 66    $ 66    —      $ 66    —

As of ~~December~~March 31, ~~2020,~~2022, the following table represents the Company’s assets and liabilities measured at fair value on a recurring basis and the basis for that measurement (in thousands):

Carrying Value
December 31, 2020

Fair Value
Measurement
December 31, 2020

Quoted Prices in
Active Markets
for Identical
Asset /
Liability (Level 1)

Significant
Other
Observable
Inputs
(Level 2)

Significant
Unobservable
Inputs
(Level 3)

Assets:

Derivative assets (other current assets)
   $ 2,036    $ 2,036    —      $ 2,036    —
Liabilities:

Derivative liabilities (other current liabilities)
   $ 195    $ 195    —      $ 195    —


	Carrying Value March 31, 2022		Fair Value Measurement March 31, 2022		Quoted Prices in Active Markets for Identical Asset / Liability (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:

Derivative assets (other non-current assets)	$	94	$	94		—	$	94		—
Liabilities:
Derivative liabilities (other current liabilities)	$	2,421	$	2,421		—	$	2,421		—
Derivative liabilities (other non-current liabilities)	$	149	$	149		—	$	149		—

As of December 31, 2021, the following table represents the Company’s liabilities measured at fair value on a recurring basis and the basis for that measurement (in thousands):


	Carrying Value December 31, 2021		Fair Value Measurement December 31, 2021		Quoted Prices in Active Markets for Identical Liability (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Liabilities:

Derivative liabilities (other current liabilities)	$	2,020	$	2,020		—	$	2,020		—

Items not reflected in the table above include cash equivalents, accounts receivable, other receivables, accounts payable, and other accounts payable, fair value of which approximate carrying values due to the short-term nature of these instruments. The fair value of assets and liabilities whose carrying value approximates fair value is determined using Level 2 inputs.

~~Fair Value of Borrowings~~

December 31, 2020


Carrying
Value

Fair
Value


(In thousands of
U.S.
dollars
)

Borrowings:

5.0% Exchangeable Senior Notes due March 2021 (Level 2)
   $ 83,479    $ 145,466
1

On January 17, 2017, the Company’s wholly owned subsidiary, MagnaChip Semiconductor S.A., closed an offering (the “Exchangeable Notes Offering”) of 5.0% Exchangeable Senior Notes due March 1, 2021 (the “Exchangeable Notes”), of $86,250 thousand, which represents the principal amount, excluding $5,902 thousand of debt issuance costs. In December 2018 and February 2019, MagnaChip Semiconductor S.A. repurchased a principal amount equal to $1,590 thousand and $920 thousand, respectively, of the Exchangeable Notes in the open market. The Exchangeable Notes matured on March 1, 2021, unless they were earlier repurchased or converted. The Company estimated the fair value of the Exchangeable Notes using the market approach, which utilizes quoted market prices that fall under Level 2. For further description of the Exchangeable Notes, see Note 11, “Borrowings.”

~~Fair Values Measured on a~~

~~Non-recurring~~

~~Basis~~

~~The Company’s~~

~~non-financial~~

assets, such as property, plant and equipment, and intangible assets are recorded at fair value upon acquisition and are remeasured at fair value only if an impairment charge is recognized. As of June 30, 2021 and 2020 the Company did 0t have any assets or liabilities

~~measured at fair value on a~~

~~non-recurring~~

~~basis.~~

17

~~Table of Contents~~

~~11. Borrowings~~

~~There were no borrowings outstanding as of June 30, 2021. As of December 31, 2020, the following table represents the Company’s borrowings (in thousands):~~

December 31,


2020

5.0% Exchangeable Senior Notes due March 2021
   $ 83,740
Less: unamortized discount and debt issuance costs
   (261 )


Total borrowings, net
   83,479
Less: current portion of long-term borrowings, net
   83,479


Long-term borrowings, net
   $ 0

~~5.0% Exchangeable Senior Notes~~

On January 17, 2017, MagnaChip Semiconductor S.A. closed the Exchangeable Notes Offering of $86,250 thousand aggregate principal amount of 5.0% Exchangeable Notes. Interest on the Exchangeable Notes accrue

d

at a rate of 5.0% per annum, payable semi-annually on March 1 and September 1 of each year, beginning on March 1, 2017. The Exchangeable Notes matured on March 1, 2021, unless they were earlier repurchased or converted. Holders had the right to convert their notes at their option at any time prior to the close of business on the business day immediately preceding the stated maturity date.

The Company incurred debt issuance costs of $5,902 thousand related to the issuance of the Exchangeable Notes. The debt issuance costs are recorded as a direct deduction from the long-term borrowings in the consolidated balance sheets and amortized to interest expense using the effective interest method over the term of the Exchangeable Notes. Interest expense related to the Exchangeable Notes for the six months ended June 30, 2021 was $958 thousand. Interest expense related to the Exchangeable Notes for the three and six months ended June 30, 2020 were $1,425 thousand and $2,841 thousand, respectively.

In February 2019, the Company repurchased a principal amount equal to $920 thousand of the Exchangeable Notes in the open market, resulting in a loss of $63 thousand, which was recorded as loss on early extinguishment of borrowings, net in the consolidated statements of operations for the year ended December 31, 2019. In December 2018, the Company repurchased a principal amount equal to $1,590 thousand of the Exchangeable Notes in the open market, resulting in a loss of $234 thousand, which was recorded as loss on early extinguishment of borrowings, net in the consolidated statements of operations for the year ended December 31, 2018.

~~Prior to the March 1, 2021 maturity of the Exchangeable Notes, holders elected to exchange all outstanding Exchangeable Notes for an aggregate of 10,144,131~~

~~shares of the Company’s common stock in satisfaction in full of the outstanding obligations under the Exchangeable Notes. Upon exchange, the Company delivered for each $1,000 principal amount of~~

~~exchanged~~

Exchangeable Notes a number of shares equal to the exchange rate of 121.1387 shares of common stock per $1,000 principal amount of Exchangeable Notes, which was equivalent to an exchange price of approximately $8.26 per share of common stock. In connection with the exchanges, the fractional shares were paid in cash. Following March 1, 2021, the Company does not have any Exchangeable Notes outstanding.

185

Table of Contents

~~12.~~9. Accrued Severance Benefits

The majority of accrued severance benefits are for employees in the Company’s Korean subsidiary. Pursuant to the Employee Retirement Benefit Security Act of Korea, eligible employees and executive officers with one or more years of service are entitled to severance benefits upon the termination of their employment based on their length of service and rate of pay. As of ~~June 30, 2021,~~March 31, 2022, 98% of all employees of the Company were eligible for severance benefits.

Changes in accrued severance benefits are as follows (in thousands):

Three Months Ended

Six Months Ended

Three Months Ended

Six Months Ended

June 30, 2021

June 30, 2020

Beginning balance
$ 52,553 $ 54,452 $ 50,610 $ 53,344
Provisions
1,736 3,507 1,755 3,774
Severance payments
(1,343 ) (2,836 ) (1,502 ) (3,454 )
Translation adjustments
159 (2,018 ) 922 (1,879 )

53,105 53,105 51,785 51,785
Less: Cumulative contributions to severance insurance deposit accounts
(13,316 ) (13,316 ) (1,570 ) (1,570 )
The National Pension Fund
(59 ) (59 ) (73 ) (73 )
Group severance insurance plan
(210 ) (210 ) (215 ) (215 )

Accrued severance benefits, net
$ 39,520 $ 39,520 $ 49,927 $ 49,927


	Three Months Ended
	March 31, 2022			March 31, 2021

Beginning balance	$	51,567		$	54,452
Provisions		1,670			1,771
Severance payments		(1,389	)		(1,493	)
Translation adjustments		(1,077	)		(2,177	)

		50,771			52,553
Less: Cumulative contributions to severance insurance deposit accounts		(17,954	)		(13,212	)
The National Pension Fund		(50	)		(61	)
Group severance insurance plan		(195	)		(210	)

Accrued severance benefits, net	$	32,572		$	39,070

The severance benefits funded through the Company’s National Pension Fund and group severance insurance plan will be used exclusively for payment of severance benefits to eligible employees. These amounts have been deducted from the accrued severance benefit balance.

Beginning in July 2018, the Company contributes to certain severance insurance deposit accounts a certain percentage of severance benefits that are accrued for eligible employees for their services from January 1, 2018. These accounts consist of time deposits and other guaranteed principal and interest, and are maintained at insurance companies, banks or security companies for the benefit of employees. The Company deducts the contributions made to these severance insurance deposit accounts from its accrued severance benefits.

The Company is liable to pay the following future benefits to its

non-executive

employees upon their normal retirement age (in thousands):


	Severance benefit		Severance benefit
Remainder of 2021	$	78
2022		258
Remainder of 2022			$	253
2023		651		631
2024		932		923
2025		2,051		1,505
2026		2,356		2,183
2027 – 2031		19,643
2027				1,746
2028 – 2032				20,679

The above amounts were determined based on the

non-executive

employees’ current salary rates and the number of service years that will be accumulated upon their retirement dates. These amounts do not include amounts that might be paid to

non-executive

employees that will cease working with the Company before their normal retirement ages.

Korea’s mandatory retirement age is 60 under the Employment Promotion for the Aged Act.

1

196

Table of Contents

~~13.~~10. Foreign Currency ~~Gain (Loss),~~Loss, Net

Net foreign currency gain or loss includes

non-cash

translation gain or loss associated with intercompany balances. A substantial portion of the Company’s net foreign currency gain or loss is

non-cash

translation gain or loss associated with intercompany long-term loans to the Company’s Korean subsidiary. The loans are denominated in U.S. dollars and are affected by changes in the exchange rate between the Korean won and the U.S. dollar. As of ~~June 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, the outstanding intercompany loan balances including accrued interest between the Korean subsidiary and the Dutch subsidiary were ~~$387,486~~$ 348,477 thousand and ~~$378,852~~$344,411 thousand, respectively. The Korean won to U.S. dollar exchange rates were ~~1,130.0:~~1,210.8:1 and ~~1,088.0:~~1,185.5:1 using the first base rate as of ~~June 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, respectively, as quoted by the KEB Hana Bank.

14

.

11. Income Taxes

The Company and its subsidiaries file income tax returns in Korea, Japan, Taiwan, the U.S. and in various other jurisdictions. The Company is subject to income or

or non-income

tax

examinations by tax authorities of these jurisdictions for all open tax years.

For the three ~~and six~~ months ended ~~June 30, 2021,~~March 31, 2022, the Company recorded an income tax expense ~~from continuing operations~~ of $

~~2,601~~

$3,483 thousand, ~~and $~~

~~2,891~~

~~thousand, respectively,~~ primarily ~~attributable~~relate

d

to ~~interest on intercompany loan balances. During the second quarter of 2021, income tax expense of $~~

~~624~~

~~thousand was also recorded for certain income-based tax assessments as a result of a regular tax examination completed for the Company’s Korean subsidiary for multiple tax year~~

s

.

~~For the three and six months ended June 30, 2020, the Company recorded an income tax expense from~~

~~continuing operations of $~~

~~678~~

~~thousand and $~~

~~1,981~~

~~thousand, respectively, primarily attributable to interest on intercompany loan balances. The income tax expense was recorded for the Company’s Korean subsidiary~~its primary operating entity in Korea based on the estimated taxable income for the respective ~~period, combined with its ability~~period.

For the three months ended March 31, 2021, the Company recorded an income tax expense of $290 thousand, primarily attributable to ~~utilize net operating~~interest on intercompany loan balances, which was offset in part by the tax benefit recognized on the loss ~~carryforwards up to~~

~~60%~~

~~in 2020.~~for the first quarter of 2021 from the Company’s Korean subsidiary.

1

207

Table of Contents

~~15.~~

12. Geographic and Other Information

The following sets forth information relating to the single ~~continuing~~ operating segment (in thousands):


	Three Months Ended				Six Months Ended				Three Months Ended
	June 30, 2021		June 30, 2020		June 30, 2021		June 30, 2020		March 31, 2022		March 31, 2021
Revenues
Standard products business

Display Solutions	$	46,601	$	69,176	$	105,496	$	146,769	$	29,185	$	58,895
Power Solutions		56,667		39,779		110,678		72,922		64,825		54,011

Total standard products business		103,268		108,955		216,174		219,691	$	94,010	$	112,906
Transitional Fab 3 foundry services		10,608		9,873		20,721		19,610		10,083		10,113

Total revenues	$	113,876	$	118,828	$	236,895	$	239,301	$	104,093	$	123,019


	Three Months Ended				Six Months Ended				Three Months Ended
	June 30, 2021		June 30, 2020		June 30, 2021		June 30, 2020		March 31, 2022		March 31, 2021
Gross Profit

Standard products business	$	32,859	$	32,138	$	66,518	$	61,268	$	37,930	$	33,659
Transitional Fab 3 foundry services		1,111		—		1,834		—		1,066		723

Total gross profit	$	33,970	$	32,138	$	68,352	$	61,268	$	38,996	$	34,382

The following is a summary of net sales—standard products business (which does not include the Transitional Fab 3 Foundry Services) by geographic region, based on the location to which the products are billed (in thousands):


									Three Months Ended
	Three Months Ended				Six Months Ended				March 31, 2022		March 31, 2021
	June 30, 2021		June 30, 2020		June 30, 2021		June 30, 2020
Korea	$	30,868	$	21,957	$	57,302	$	52,774	$	31,030	$	26,434
Asia Pacific (other than Korea)		69,352		84,210		153,092		161,752		58,260		83,740
United States		1,363		1,461		2,637		2,170		2,864		1,274
Europe		1,206		856		2,449		1,827		1,856		1,243
Others		479		471		694		1,168		0		215

Total	$	103,268	$	108,955	$	216,174	$	219,691	$	94,010	$	112,906

For the three months ended ~~June 30,~~March 31, 2022 and 2021, ~~and 2020,~~ of the Company’s net sales – standard products business in Asia Pacific (other than Korea), net sales – standard products business in China and Hong Kong

together

represented ~~60.6%~~71.1% and ~~82.8%~~57.1%, respectively, and net sales—standard products business in Vietnam represented ~~32.0%~~14.4% and 13.8%, respectively. For the six months ended June 30, 2021 and 2020, of the Company’s net sales – standard products business in Asia Pacific (other than Korea), net sales – standard products business in China and Hong Kong represented 58.6% and 88.8%, respectively, and net sales—standard products business in Vietnam represented 35.0% and 7.7%37.4%, respectively.

Net sales from the Company’s top ten largest customers in the standard products business (which does not include the Transitional Fab 3 Foundry Services) accounted for ~~80%~~72% and ~~88%~~82% for the three months ended ~~June 30,~~March 31, 2022 and 2021, ~~and 2020, respectively, and 81% and 89%~~

~~for the six months ended June 30, 2021 and 2020,~~ respectively.

For the three months ended ~~June 30,~~March 31, 2022, the Company had two customers that represented 25.5% and 12.9% of its net sales – standard products business

, respectively.

For the three months ended March 31, 2021, the Company had two customers that represented ~~40.0%~~48.8% and ~~11.7%~~10.0% of its net sales – standard products business. For the six months ended June 30, 2021, the Company had two customers that represented 44.6% and 10.8% of its net sales – standard products business. For the three months ended June 30, 2020, the Company had one customer that represented 56.5% of its net sales – standard products business ~~and for the six months ended June 30, 2020, the Company had two customers that represented 54.7% and 10.7% of its net sales – standard products business.~~

, respectively.

As of ~~June 30, 2021~~March 31, 2022, two customers accounted for 17.0% and 16.7% of accounts receivable, respectively. As of December 31, ~~2020, one customer~~2021, two customers accounted for ~~26.9%~~25.6% and ~~45.1%~~18.6% of accounts receivable, respectively.

1

21

~~Table of Contents~~

~~16. Accumulated Other Comprehensive Income (Loss)~~

~~Accumulated other comprehensive income (loss) consists of the following as of June 30, 2021 and December 31, 2020, respectively (in thousands):~~

June 30,
2021

December 31,
2020

Foreign currency translation adjustments
   $ 120    $ 2,069
Derivative adjustments
   (1,045 )    1,634




Total
   $ (925 )    $ 3,703

~~Changes in accumulated other comprehensive income (loss) for the three months ended June 30, 2021 and 2020 are as follows (in thousands):~~

Three Months Ended June 30, 2021

Foreign
currency
translation
adjustments

Derivative
adjustments

Total

Beginning balance
   $ 11    $ (1,002 )    $ (991 )






Other comprehensive income before reclassifications
   109    432    541
Amounts reclassified from accumulated other comprehensive income
   —      (475 )    (475 )






Net current-period other comprehensive income (loss)
   109    (43 )    66






Ending balance
   $ 120    $ (1,045 )    $ (925 )

Three Months Ended June 30, 2020

Foreign
currency
translation
adjustments

Derivative
adjustments

Total

Beginning balance
   $ 18,046    $ (3,401 )    $ 14,645






Other comprehensive income (loss) before reclassifications
   (6,543 )    2,204    (4,339 )
Amounts reclassified from accumulated other comprehensive loss
   —      193    193






Net current-period other comprehensive income (loss)
   (6,543 )    2,397    (4,146 )






Ending balance
   $ 11,503    $ (1,004 )    $ 10,499

~~Changes in accumulated other comprehensive income (loss) for the six months ended June 30, 2021 and 2020 are as follows (in thousands):~~

Six Months Ended June 30, 2021

Foreign
currency
translation
adjustments

Derivative
adjustments

Total

Beginning balance
   $ 2,069    $ 1,634    $ 3,703






Other comprehensive loss before reclassifications
   (1,949 )    (1,693 )    (3,642 )
Amounts reclassified from accumulated other comprehensive income
   —      (986 )    (986 )






Net current-period other comprehensive loss
   (1,949 )    (2,679 )    (4,628 )






Ending balance
   $ 120    $ (1,045 )    $ (925 )

Six Months Ended June 30, 2020

Foreign
currency
translation
adjustments

Derivative
adjustments

Total

Beginning balance
   $ (4,205 )    $ 1,545    $ (2,660 )






Other comprehensive income (loss) before reclassifications
   15,708    (2,800 )    12,908
Amounts reclassified from accumulated other comprehensive loss
   —      251    251






Net current-period other comprehensive income (loss)
   15,708    (2,549 )    13,159






Ending balance
   $ 11,503    $ (1,004 )    $ 10,499

228

Table of Contents

~~17.~~

13. Accumulated Other Comprehensive Loss

Accumulated other comprehensive loss consists of the following as of March 31, 2022 and December 31, 2021, respectively (in thousands):


	March 31, 2022			December 31, 2021

Foreign currency translation adjustments	$	(3,815	)	$	(770	)
Derivative adjustments		(1,962	)		(1,460	)

Total	$	(5,777	)	$	(2,230	)

Changes in accumulated other comprehensive loss for the three months ended March 31, 2022 and 2021 are as follows (in thousands):


Three Months Ended March 31, 2022	Foreign currency translation adjustments			Derivative adjustments			Total

Beginning balance	$	(770	)	$	(1,460	)	$	(2,230	)

Other comprehensive loss before reclassifications		(3,045	)		(1,264	)		(4,309	)
Amounts reclassified from accumulated other comprehensive loss		—			762			762

Net current-period other comprehensive loss		(3,045	)		(502	)		(3,547	)

Ending balance	$	(3,815	)	$	(1,962	)	$	(5,777	)


Three Months Ended March 31, 2021	Foreign currency translation adjustments			Derivative adjustments			Total

Beginning balance	$	2,069		$	1,634		$	3,703

Other comprehensive loss before reclassifications		(2,058	)		(2,125	)		(4,183	)
Amounts reclassified from accumulated other comprehensive income		—			(511	)		(511	)

Net current-period other comprehensive loss		(2,058	)		(2,636	)		(4,694	)

Ending balance	$	11		$	(1,002	)	$	(991	)

19

Table of Contents

14. Stockholders’ Equity

Accelerated Stock Repurchase Program

On December 21, 2021, the Board of Directors authorized the Company to repurchase up to $75,000 thousand of the Company’s outstanding common stock and the Company entered into an accelerated stock repurchase agreement (the “ASR Agreement”) with JPMorgan Chase Bank, National Association (“JPM”) to repurchase an aggregate of $37,500 thousand of the Company’s common stock.

Pursuant to the terms of the ASR Agreement dated December 21, 2021, the Company paid to JPM $37,500 thousand in cash and received an initial delivery of 994,695 shares of its common stock in the open market for an aggregate purchase price of $20,073 thousand and a price per share of $20.18 on December 22, 2021.

As of December 31, 2021, the Company accounted for the remaining portion of the ASR Agreement as a forward contract indexed to its own common stock and recorded $17,427 thousand in additional

paid-in

capital in stockholders’ equity in its consolidated balance sheets.

In March 2022, the previously announced repurchase of $37,500 thousand of the Company’s common stock was completed pursuant to the ASR Agreement, and as a result, the Company additionally received 1,031,576 shares of its common stock for an aggregate purchase price of $ 17,217 thousand at a price per share of $16.69, which was reclassified as a treasury stock from additional

paid-in

capital in stockholder’s equity in its consolidated balance sheets.

20

Table of Contents

15. Earnings (Loss) Per Share

The following table illustrates the computation of basic and diluted earnings (loss) per common share for the three ~~and six~~ months ended ~~June 30, 2021~~March 31, 2022 and ~~2020:~~2021:

Three Months Ended

Six Months Ended


June 30,
2021

June 30,
2020

June 30,
2021

June 30,
2020


(In thousands of U.S. dollars, except share data)

Basic earnings (loss) per share

Income (loss) from continuing operations
   $ (198 )    $ 11,774    $ (7,671 )    $ (19,304 )
Income from discontinued operations, net of tax
   0      17,397    0      24,726








Net income (loss)
   $ (198 )    $ 29,171    $ (7,671 )    $ 5,422








Basic weighted average common stock outstanding
   46,322,027    35,092,312    43,324,088    34,992,734
Basic earnings (loss) per common share

Continuing operations
   $ (0.00 )    $ 0.34    $ (0.18 )    $ (0.55 )
Discontinued operations
   0      0.50    0      0.71








Total
   $ (0.00 )    $ 0.84    $ (0.18 )    $ 0.16








Diluted earnings (loss) per share

Income (loss) from continuing operations
   $ (198 )    $ 11,774    $ (7,671 )    $ (19,304 )
Add back: Interest expense on Exchangeable Notes
   0      1,425    0      0








Income (loss) from continuing operations allocated to common stockholders    $ (198 )    $ 13,199    $ (7,671 )    $ (19,304 )
Income from discontinued operations, net of tax
   0      17,397    0      24,726








Net income (loss) allocated to common stockholders
   $ (198 )    $ 30,596    $ (7,671 )    $ 5,422








Basic weighted average common stock outstanding
   46,322,027    35,092,312    43,324,088    34,992,734
Net effect of dilutive equity awards
   0      1,237,770    0      0
Net effect of assumed conversion of 5.0% Exchangeable Notes to common stock    0      10,144,155    0      0








Diluted weighted average common stock outstanding
   46,322,027    46,474,237    43,324,088    34,992,734
Continuing operations
   $ (0.00 )    $ 0.28    $ (0.18 )    $ (0.55 )
Discontinued operations
   0      0.37    0      0.71








Total
   $ (0.00 )    $ 0.65    $ (0.18 )    $ 0.16


	Three Months Ended
	March 31, 2022		March 31, 2021
	(In thousands of U.S. dollars, except share data)

Basic Earnings (Loss) per Share

Net income (loss)	$	9,528	$	(7,473	)

Basic weighted average common stock outstanding		45,603,208		40,292,838
Basic earnings (loss) per share	$	0.21	$	(0.19	)
Diluted Earnings (Loss) per Share
Net income (loss)	$	9,528	$	(7,473	)

Basic weighted average common stock outstanding		45,603,208		40,292,838
Net effect of dilutive equity awards		1,090,086		0

Diluted weighted average common stock outstanding		46,693,294		40,292,838
Diluted earnings (loss) per share	$	0.20	$	(0.19	)

The following outstanding instruments were excluded from the computation of diluted ~~earnings (loss)~~loss per share, as they have an anti-dilutive effect on the calculation:


	Three Months Ended				Six Months Ended				Three Months Ended
	June 30, 2021		June 30, 2020		June 30, 2021		June 30, 2020		March 31, 2022		March 31, 2021
Options		1,470,421		699,167		1,470,421		2,075,494		130,000		1,471,421
Restricted Stock Units		1,012,197		0		1,012,197		1,238,639		0		1,109,572

For the ~~six~~three months ended ~~June 30,~~March 31, 2021, ~~and 2020, 2,875,982~~5,783,919 shares ~~and 10,144,155 shares, respectively,~~ of potential common stock from the assumed conversion of Exchangeable Notes were ~~also~~ excluded from the computation of diluted loss per share as the effect were anti-dilutive for the period.

Rights Plan

The Company entered into a Rights Agreement, dated as of December 13, 2021, between the Company and American Stock Transfer & Trust Company, LLC, as rights agent (the “Rights Agreement”), and the Board of Directors of the Company authorized and declared a dividend of one preferred stock purchase right (a “Right” and collectively, the “Rights”) for each share of the Company’s common stock, par value $0.01 per share, outstanding at the close of business on December 23, 2021. Each Right, once exercisable, will entitle the registered holder to purchase from the Company one

one-thousandth

of a share of Series

A-1

Junior Participating Preferred Stock, par value $0.01 per share, at a purchase price of $80, subject to adjustment (the “Purchase Price”). The Rights are not presently exercisable and remain attached to the shares of common stock unless and until the occurrence of the earlier of the following (the “Distribution Date”): (i) the tenth day after the public announcement or disclosure by the Company or any person or group of affiliated or associated persons that any person or group of affiliated or associated persons has become an “Acquiring Person” by obtaining beneficial ownership of 12.5% (or 20% in the case of a “passive institutional investor,” which is defined generally as any person who has reported beneficial ownership of shares of common stock on Schedule 13G under the Securities Exchange Act of 1934) or more of the Company’s outstanding common stock, subject to certain exceptions; or (ii) the tenth business day (or such later date as the Company’s Board of Directors may designate before a person or group of affiliated or associated persons becomes an Acquiring Person) after (and not including) the commencement of, or first public announcement of the intent of any person to commence, a tender or exchange offer by any person or group of affiliated or associated persons, which would, if consummated, result in such person or group becoming an Acquiring Person. The Board of Directors may redeem all of the Rights for $0.001 per Right at any time before any person or group of affiliated or associated persons becomes an Acquiring Person. In addition, at any time on or after any person or group of affiliated or associated persons becomes an Acquiring Person (but before any person or group of affiliated or associated persons becomes the owner of 50% or more of the Company’s outstanding common stock), the Board of Directors may exchange all or part of the Rights (other than the Rights beneficially owned by the Acquiring Person and certain affiliated persons) for shares of common stock at an exchange ratio of one share of common stock per Right. The Rights will expire at the close of business on December 12, 2022, unless redeemed or exchanged prior to that time.

2321

Table of Contents

If any person or group of affiliated or associated persons becomes an Acquiring Person, then, after the Distribution Date, each Right (other than Rights beneficially owned by the Acquiring Person and certain affiliated persons or transferees thereof) will entitle the holder to purchase, for the Purchase Price, a number of shares of common stock having a market value of twice the Purchase Price. Alternatively, if, after any person or group of affiliated or associated persons becomes an Acquiring Person, (1) the Company is involved in a merger or other business combination in which the Company is not the surviving corporation or its common stock is changed into or exchanged for other securities or assets; or (2) the Company or one or more of its subsidiaries sell or otherwise transfer assets or earning power aggregating more than 50% of the assets or earning power of the Company and its subsidiaries, taken as a whole, then each Right (other than Rights beneficially owned by the Acquiring Person and certain affiliated persons) will entitle the holder to purchase, for the Purchase Price, a number of shares of common stock of the other party to such business combination or sale (or in certain circumstances, an affiliate) having a market value of twice the Purchase Price.

22

Table of Contents

~~18. Other Charges~~16. Merger Agreement

On March 25, 2021, the Company, South Dearborn Limited, an exempted company incorporated in the Cayman Islands with limited liability (“Parent”), formed by an affiliate of Wise Road Capital LTD (“Wise Road”), and Michigan Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), entered into an Agreement and Plan of Merger (as amended, the “Merger Agreement”), providing for, among other things and subject to the terms and conditions thereof, the merger of Merger Sub with and into the Company (the “Merger”), with the Company surviving the Merger as a wholly owned subsidiary of Parent.

The closing of the Merger was subject to certain conditions, including clearance by the Committee on Foreign Investment in the United States (“CFIUS”) under the Defense Production Act of 1950, as amended. The Company and Parent were advised that CFIUS clearance of the Merger would not be forthcoming and received permission from CFIUS to withdraw their joint filing. In connection therewith, the Company and Parent entered into a Termination and Settlement Agreement, dated December 13, 2021 (the “Termination Agreement”), pursuant to which Parent agreed to pay $70,200 thousand (the “Termination Fee”) to the Company on the terms specified in the Termination Agreement in satisfaction of Parent’s obligation to pay a termination fee in connection with the termination of the Merger Agreement.

On December 20, 2021, the Merger Agreement was terminated pursuant to the Termination Agreement after the Company’s receipt of a fee of $51,000 thousand from Parent and a standby letter of credit, which secures a deferred fee of $19,200 thousand from Parent due on or before March 31, 2022.

As of March 31, 2022, of the Termination Fee, $19,200 thousand deferred fee was recorded as other receivables.

For the three months ended ~~June 30,~~March 31, 2021, ~~other charges~~

~~totaled $~~

~~5,020~~

the Company incurred $9,831 thousand of

~~which $~~

~~2,459~~

~~thousand related to~~ professional fees and certain transaction ~~related expenses~~related-expenses incurred in connection with the Merger, ~~and $2,561 thousand related to certain~~

~~non-recurring~~

~~professional fees and expenses~~which were recognized in ~~connection with regulatory requests.~~merger-related costs in the consolidated statements of operations.

~~For the six months ended June 30, 2021, other charges totaled~~

~~$15,436~~

~~thousand, of which~~

~~$12,290~~

~~thousand related to professional fees and certain transaction related expenses incurred in connection with the Merger and~~

~~$3,146~~

~~thousand related to certain~~

~~non-recurring~~

~~professional fees and expenses in connection with regulatory requests. For the six months ended June 30, 2020, other charges were~~

~~$554~~

~~thousand, which pertained to~~

~~non-recurring~~

~~professional service fees and expenses incurred in connection with certain treasury and finance initiatives.~~

2423

Table of Contents

~~19.~~17. Commitments and Contingencies

Advances to Suppliers

The Company, from time to time, may make advances in form of prepayments or deposits to suppliers, ~~to procure materials~~including external foundries, to meet its planned production. The Company recorded advances of ~~$1,150~~$8,001 thousand and ~~$5,500~~$1,708 thousand as other current assets as of ~~June 30, 2021~~March 31, 2022 and December 31, ~~2020,~~2021, respectively.

COVID-19

Pandemic

In December 2019, a strain of coronavirus causing a disease known as

COVID-19

surfaced in Wuhan, China, resulting in significant disruptions among Chinese manufacturing and other facilities and travel throughout China. In March 2020, the World Health Organization declared the

COVID-19

outbreak a pandemic. Governmental authorities throughout the world have implemented numerous containment measures, including travel bans and restrictions, quarantines,

shelter-in-place

orders, and business restrictions and shutdowns, resulting in rapidly changing market and economic conditions. Although some of these restrictions and other containment measures have since been lifted or scaled back, ongoing surges of

COVID-19

have in some cases resulted in the

re-imposition

of certain restrictions and containment measures, and may continue to lead to other restrictions being

re-implemented

in the foreseeable future in response to efforts to reduce the rapid spread of

COVID-19.

The Company experienced some minor disruption in its Power Solutions business from assembly and test subcontractors located in China in the first quarter of 2020 as a result of the

COVID-19

pandemic. To date, its external Display Solutions business contractors and

sub-contractors

have not been materially impacted by the

COVID-19

pandemic. The Company is, however, unable to accurately predict the full impact that the

COVID-19

pandemic will have on its future results of operations due to numerous ~~uncertainties,~~uncertainties. The extent to which the

COVID-19

pandemic impacts the Company’s business, results of operations and financial condition will depend on future developments, which, despite progress in vaccination efforts, are highly uncertain and cannot be predicted with confidence, including the ~~severity and~~ duration of the outbreak, new information that may emerge concerning the ~~efficacy of ongoing global vaccination efforts, potential future recurrences~~severity of the ~~outbreak,~~

COVID-19

pandemic, such as new strains of the ~~spread of disease~~virus, including the Delta and Omicron variants and any future variants that may ~~be resistant~~emerge, which may impact rates of infection and vaccination efforts, developments or perceptions regarding the safety of vaccines and the extent and effectiveness of actions to contain the

COVID-19

pandemic or treat its impact, including vaccination campaigns and lockdown measures, among others. In addition, recurrences or additional waves of

COVID-19

cases could cause other widespread or more severe impacts depending on where infection rates are highest. The Company cannot presently predict the ~~existing vaccines, further containment actions that may be taken by governmental authorities,~~scope and severity of any potential business shutdowns or disruptions, but if the ~~impact to the businesses~~Company or any of its customers and suppliers were to experience prolonged business shutdowns or other disruptions, its ability to conduct its business could be materially and ~~other factors.~~negatively affected, which could have a material adverse impact on its business, results of operations and financial condition.

The Company continues to closely monitor and evaluate the nature and scope of the impact of the

COVID-19

pandemic to its business, consolidated results of operations, and financial condition, and may take further actions altering its business operations and managing its costs and liquidity that the Company deems necessary or appropriate to respond to this ~~fast moving~~ongoing and uncertain global health crisis and the resulting global economic consequences.

~~Merger-related Complaints~~

18. Subsequent Events

~~Since~~

The Terminated Merger

The Merger Agreement was previously terminated on December 20, 2021 pursuant to the Termination Agreement following the Company’s receipt of a portion of the Termination Fee equal to $51,000 thousand from Parent and the issuance of a standby letter of credit, which secured a deferred portion of the Termination Fee equal to $19,200 thousand from Parent due on or before March 31, 2022. In connection therewith, the Company,

Parent and Wise Road entered into a first amendment to the Termination Agreement, dated April ~~22, 2021, eleven complaints (each, a “Shareholder Complaint,”~~4, 2022, pursuant to which Parent agreed to pay the Company $19,200 thousand, of which $14,400 thousand has been paid on April 4, 2022 and ~~together,~~payment of the ~~“Shareholder Complaints”) have been filed seeking to enjoin the Merger, or, if the Merger~~remaining $4,800 thousand (which amount is ~~consummated, rescind the Merger or recover damages, as well as an award of each plaintiff’s fees and litigation expenses. The Shareholder Complaints, each filed as an individual action~~secured by a ~~purported stockholder~~new standby letter of ~~the Company, are captioned as~~credit, dated April 4, 2022), will be paid by Parent on or before June 30, 2022.

~~Schulthess v. Magnachip Semiconductor Corporation, et al.~~

Derivative contracts

~~, Case No.~~

~~1:21-cv-03587~~

~~(S.D.N.Y.) (the “Schulthess Complaint”),~~

~~Pittman v. Magnachip Semiconductor Corporation, et al.~~

~~, Case No.~~

~~1:21-cv-02306~~

~~(E.D.N.Y.),~~

~~Flanagan v. Magnachip Semiconductor Corporation, et al.~~

~~, Case No.~~

~~1:21-cv-03743~~

~~(S.D.N.Y.),~~

~~Castelli v. Magnachip Semiconductor Corporation, et al.~~

~~, Case No.~~

~~1:21-cv-03769~~

~~(S.D.N.Y.) (the “Castelli Complaint”),~~

~~Doolittle v. Magnachip Semiconductor Corporation, et al.~~

~~, Case No.~~

~~1:21-cv-03801~~

~~(S.D.N.Y.),~~

~~Thomas v. Magnachip Semiconductor Corporation, et al.~~

~~, Case No.~~

~~1:21-cv-03860~~

~~(S.D.N.Y.),~~

~~Finger v. Magnachip Semiconductor Corporation, et al.~~

~~, Case No.~~

~~1:21-cv-03927~~

~~(S.D.N.Y.),~~

~~Kent v. Magnachip Semiconductor Corporation, et al.~~

~~, Case No.~~

~~1:21-cv-00657~~

~~(D. Del.),~~

~~Kennedy v. Magnachip Semiconductor Corporation, et al.~~

~~, Case No.~~

~~2:21-cv-02110~~

~~(E.D. Pa.),~~

~~Monroy v. Magnachip Semiconductor Corporation, et al.~~

~~, Case No.~~

~~1:21-cv-04921~~

~~(S.D.N.Y.) (the “Monroy Complaint”), and~~

~~Jones v. Magnachip Semiconductor Corporation, et al.~~

~~, Case No.~~

~~1:21-cv-04966~~

~~(S.D.N.Y.). Each Shareholder Complaint alleges either that the preliminary proxy statement filed by the Company with the Securities and Exchange Commission (“SEC”) on~~In April 19, 2021 or the definitive proxy statement filed by the Company with the SEC on May 7, 2021, is false and/or misleading and asserts claims for violations of Section 14(a) and 20(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and SEC Rule

~~14a-9~~

~~against~~2022, the Company and ~~certain current or former members~~NFIK entered into derivative contracts of zero cost collars for the ~~Company’s board of directors (the “Board”).~~period from April 2023 to December 2023. The ~~Schulthess Complaint, Castelli Complaint and Monroy Complaint also allege breaches of fiduciary duties by certain current or former members of the Board. The Schulthess Complaint further alleges that~~total notional amounts are $33,000 thousand.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following discussion and analysis should be read in conjunction with the unaudited consolidated financial statements and the related notes included elsewhere in this Report.

Overview

We are a designer and manufacturer of analog and mixed-signal semiconductor platform solutions for communications, IoT applications, consumer, computing, industrial and automotive applications. We ~~provide technology platforms for analog, mixed-signal, power, high voltage,~~

~~non-volatile~~

~~memory, and radio frequency applications. We~~ have a proven record with more than 40 years of operating history, a portfolio of approximately ~~1,200~~1,150 registered patents and pending applications and extensive engineering and manufacturing process expertise.

Our standard products business includes our Display Solutions and Power Solutions business lines.

Our Display Solutions line of products ~~provides~~provide flat panel display solutions to major suppliers of large and small flat panel displays. These products include source and gate drivers and timing controllers that cover a wide range of flat panel displays used in mobile communications, automobiles, entertainment devices, notebook PCs, monitors and liquid crystal display (LCD) ~~and~~, organic light emitting diodes (OLED). and Micro light emitting diode (Micro LED) televisions. Our Display Solutions products support some of the industry’s most advanced display technologies, such as OLEDs, low temperature polysilicons thin film transistors (LTPS TFTs) ~~and~~, as well as high-volume display technologies such as amorphous silicon thin film transistors

(a-Si

TFTs). Since 2007, we have designed and manufactured OLED display driver integrated circuit (IC) products. Our current portfolio of OLED solutions address a wide range of resolutions ranging from HD (High Definition) to ~~Wide Quad~~WQHD (Wide Quadruple High ~~Definition (WQHD)~~Definition) for applications including smartphones, TVs, and other mobile devices.

Our Power Solutions business line produces power management semiconductor products including discrete and integrated circuit solutions for power management in communications, consumer, ~~communications,~~ computing, ~~industrial~~servers, automotive, and ~~automotive~~industrial applications. These products include metal oxide semiconductor field effect transistors (MOSFETs), insulated-gate bipolar transistors (IGBTs),

~~AC-DC~~

AC-DC/DC-DC

~~converters,~~

~~DC-DC~~

converters, LED drivers, ~~switching~~ regulators ~~linear regulators, interface ICs~~ and power management ~~ICs~~integrated circuits (PMICs) for a range of devices, including televisions, smartphones, mobile phones, wearable devices, desktop PCs, notebooks, ~~tablets, servers, telecommunication power, home appliances,~~tablet PCs, other consumer electrics, automotive, and industrial applications such as ~~uninterruptible~~ power ~~supplies (UPSs),~~suppliers,

e-bikes,

solar inverters, LED lighting ~~personal mobility,~~and motor ~~drives and battery management systems (BMS).~~drives.

Our wide variety of analog and mixed-signal semiconductor products combined with our mature technology platform allow us to address multiple high-growth end markets and rapidly develop and introduce new products and services in response to market demands. Our design center and substantial manufacturing operations in Korea place us at the core of the global electronics device supply chain. We believe this enables us to quickly and efficiently respond to our customers’ needs, and allows us to better serve and capture additional demand from existing and new customers. Certain of our OLED products are produced using external

12-inch

foundries. Through a strategic cooperation with external

12-inch

foundries, we are managing to ensure outsourcing wafers at competitive price and produce quality products.

To maintain and increase our profitability, we must accurately forecast trends in demand for electronics devices that incorporate semiconductor products we produce. We must understand our customers’ needs as well as the likely end market trends and demand in the markets they serve. We must also invest in relevant research and development activities and purchase necessary materials on a timely basis to meet our customers’ demand while maintaining our target margins and cash flow.

The semiconductor markets in which we participate are highly competitive. The prices of our products tend to decrease regularly over their useful lives, and such price decreases can be significant as new generations of products are introduced by us or our competitors. We strive to offset the impact of declining selling prices for existing products through cost reductions and the introduction of new products that command selling prices above the average selling price of our existing products. In addition, we seek to manage our inventories and manufacturing capacity so as to mitigate the risk of losses from product obsolescence.

Demand for our products and services is driven by overall demand for communications, IoT, consumer and industrial products and can be adversely affected by periods of weak consumer and enterprise spending or by market share losses by our customers. In order to mitigate the impact of market volatility on our business, we ~~are diversifying~~continually strive to diversify our portfolio of products, customers, and target applications. We also expect that new competitors will emerge in these markets that may place increased pressure on the pricing for our products and services. While we believe we are well positioned competitively to compete in these markets and against these new competitors as a result of our long operating history, existing manufacturing capacity and our worldwide customer base, if we are not effective in competing in these markets, our operating results may be adversely affected.

2826

Table of Contents

Net sales for our standard products business are driven by design wins in which we are selected by an electronics original equipment manufacturer (OEM) or other potential customer to supply its demand for a particular product. A customer will often have more than one supplier designed into multi-source components for a particular product line. Once we have design wins and the products enter into mass production, we often specify the pricing of a particular product for a set period of time, with periodic discussions and renegotiations of pricing with our customers. In any given period, our net sales depend heavily upon the

end-market

demand for the goods in which our products are used, the inventory levels maintained by our customers and, in some cases, allocation of demand for components for a particular product among selected qualified suppliers.

In contrast to completely fabless semiconductor companies, our internal manufacturing capacity provides us with greater control over certain manufacturing costs and the ability to implement process and production improvements for our internally manufactured products, which can favorably impact gross profit margins. Our internal manufacturing capacity also allows for better control over delivery schedules, improved consistency over product quality and reliability and improved ability to protect intellectual property from misappropriation on these internally manufactured products. However, having internal manufacturing capacity exposes us to the risk of under-utilization of manufacturing capacity that results in lower gross profit margins, particularly during downturns in the semiconductor industry.

Our standard products business requires investments in capital equipment. Analog and mixed-signal manufacturing facilities and processes are typically distinguished by the design and process implementation expertise rather than the use of the most advanced equipment. Many of these processes also tend to migrate more slowly to smaller geometries due to technological barriers and increased costs. For example, some of our products use high-voltage technology that requires larger geometries and that may not migrate to smaller geometries for several years, if at all. As a result, our manufacturing base and strategy do not require substantial investment in leading edge process equipment for those products, allowing us to utilize our facilities and equipment over an extended period of time with moderate required capital investments. In addition, we are less likely to experience significant industry overcapacity, which can cause product prices to decline significantly. In general, we seek to invest in manufacturing capacity that can be used for multiple high-value applications over an extended period of time. In addition, we outsource manufacturing of those products which do require advanced technology and

12-inch

and

8-inch

wafer capacity, such as organic light emitting diodes (OLED). We believe this balanced capital investment strategy enables us to optimize our capital investments and facilitates more diversified product and service offerings.

Since 2007, we had designed and manufactured OLED display driver ICs in our internal manufacturing facilities. As we expanded our design capabilities to products that require lower geometries unavailable at our existing manufacturing facilities, we began outsourcing manufacturing of certain OLED display driver ICs to an external

12-inch

~~foundry~~foundries starting in the second half of ~~2015.~~2015 and we have started outsourcing

8-inch

wafer for OLED TV IC after the sale of our fabrication facility located in Cheongju. This additional source of manufacturing is an increasingly important part of our supply chain management. By outsourcing manufacturing of OLED products to external

~~12-inch~~

foundries, we are able to adapt dynamically to changing customer requirements and address growing markets without substantial capital investments by us. However, relying on external foundries exposes us to the risk of being unable to secure manufacturing capacity, particularly under the current global shortage of foundry services. Although we are working strategically with external foundries to ~~secure~~ensure long-term wafer capacity, if wethese efforts are unsuccessful, our ability to deliver products to our customers may be negatively impacted, which would adversely affect our relationship with customers and opportunities to secure new design-wins.

Our success going forward will depend upon our ability to adapt to future challenges such as the emergence of new competitors for our products and services or the consolidation of current competitors. Additionally, we must innovate to remain ahead of, or at least rapidly adapt to, technological breakthroughs that may lead to a significant change in the technology necessary to deliver our products and services. We believe that our established relationships and close collaboration with leading customers enhance our awareness of new product opportunities, market and technology trends and improve our ability to adapt and grow successfully.

2927

Table of Contents

Recent Developments

~~The Merger~~Accelerated Stock Repurchase Program

On ~~March 25,~~December 21, 2021, our Board of Directors authorized the repurchase of up to $75.0 million of our outstanding common stock and we entered into ~~the Merger Agreement~~an accelerated stock repurchase agreement (the “ASR Agreement”) with ~~Parent and Merger Sub, pursuant~~JPMorgan Chase Bank, National Association (“JPM”) to which, among other things, and subject to the terms and conditions thereof, Merger Sub will be merged with and into the Company, with the Company continuing its corporate existence as the surviving corporation in the Merger and becoming a wholly owned subsidiaryrepurchase an aggregate of ~~Parent.~~$37.5 million of our common stock.

~~Under~~

Pursuant to the terms of the ~~Merger~~ASR Agreement ~~each share of our common stock issued and outstanding immediately before the Effective Time (other than Excluded Shares and Dissenting Shares) will be cancelled and will cease~~dated December 21, 2021, we paid to ~~exist and will be automatically converted into the right to receive $29.00~~JPM $37.5 million in cash ~~without interest,~~ and ~~subject to applicable withholding taxes. The~~

~~all-cash~~

~~transaction has~~received an ~~equity value~~initial delivery of ~~approximately $1.4 billion. The Merger is fully backed by equity commitments and not contingent on any financing conditions.~~

~~We have incurred, and will continue to incur, significant costs, expenses and fees for professional services and other transaction costs in connection with the Merger.~~

For more information on the Merger Agreement and the Merger, see “Item 1. Interim Consolidated Financial Statements—Notes to Consolidated Financial Statements—Note 2. Merger Agreement” in this Report.

~~Conversion of 5.0% Exchangeable Senior Notes due 2021 (the “Exchangeable Notes”)~~

~~Prior to the March 1, 2021 maturity of our Exchangeable Notes, holders thereof elected to exchange the Exchangeable Notes for an aggregate of 10,144,131~~994,695 shares of our common stock in ~~satisfaction in full~~the open market for an aggregate purchase price of $20.1 million at a price per share of $20.18 on December 22, 2021.

As of December 31, 2021, we accounted for the remaining portion of the ~~outstanding obligations under~~ASR Agreement as a forward contract indexed to our common stock and recorded $17.4 million in additional

paid-in

capital in stockholders’ equity in our consolidated balance sheets.

In March 2022, the ~~Exchangeable Notes. On~~previously announced repurchase of $37.5 million of our common stock was completed pursuant to the ASR Agreement, and as a result, we additionally received 1,031,576 shares of our common stock for an aggregate purchase price of $17.2 million at a price per share of $16.69, which was reclassified as a treasury stock from additional

paid-in

capital in stockholder’s equity in our consolidated balance sheets.

Additional details about the ASR Agreement are contained in the Current Report on Form

8-K

filed by us with the Securities and Exchange Commission, or the SEC on March ~~1, 2021,~~14, 2022.

Global Semiconductor Chip Shortage

Recent sharp increases in demand for semiconductor products have resulted in a global shortage of manufacturing capacity. As a result, we ~~paid~~may experience increased costs to manufacture our products and may not be able to manufacture and deliver all of the ~~final interest payment~~orders placed by our customers. Specifically, if we are unable to secure manufacturing capacity from the external foundries we rely on, our ability to deliver products to our customers may be negatively impacted. Also, this shortage of manufacturing capacity may lead to an increase in our manufacturing costs. Our principal pricing strategy is to pass on the ~~Exchangeable Notes~~increased manufacturing costs to our customers; however, we may not be fully able to do this in all cases. Total revenues for the three months ended March 31, 2022 were severely impacted by these persisting supply shortages, in particular for 28nm

12-inch

OLED wafers.

In an effort to minimize the potential adverse impact of ~~$2.1 million~~the supply shortage, we are working strategically with certain external foundries to help ensure long-term wafer capacity. If these efforts are unsuccessful, however, such shortage could limit our ability to meet demand for our products in the future, which would adversely affect our reputation and ~~no longer have any Exchangeable Notes obligations outstanding as~~competitive position, resulting in a negative impact on results of ~~such date.~~operations.

We are not able to foresee when the current shortage of manufacturing capacity will subside. A prolonged global supply shortage could negatively impact our financial condition, potentially resulting in a need for additional capital to fund strategic initiatives or operating activities.

COVID-19

Pandemic

In December 2019, a strain of coronavirus causing a disease known as

COVID-19

surfaced in Wuhan, China, resulting in significant disruptions among Chinese manufacturing and other facilities and travel throughout China. In March 2020, the World Health Organization declared the

COVID-19

outbreak a pandemic. Governmental authorities throughout the world have implemented numerous containment measures, including travel bans and restrictions, quarantines,

shelter-in-place

orders, and business restrictions and shutdowns, resulting in rapidly changing market and economic conditions. Although some of these restrictions and other containment measures have since been lifted or scaled back, ongoing surges of

COVID-19

have, in some cases, resulted in the

re-imposition

of certain restrictions and containment measures, and may continue to lead to other restrictions being

re-implemented

in the foreseeable future in response to efforts to reduce the rapid spread of

COVID-19.

We experienced some minor disruption in our Power Solutions business from assembly and test subcontractors located in China in the first quarter of 2020 as a result of the

COVID-19

pandemic. To date, our external Display Solutions business contractors and

sub-contractors

have not been materially impacted by the

COVID-19

pandemic. We are, however, unable to accurately predict the full impact that the

COVID-19

pandemic will have on future results of operations due to numerous ~~uncertainties,~~uncertainties. The extent to which the

COVID-19

pandemic impacts our business, results of operations and financial condition will depend on future developments, which, despite progress in vaccination efforts, are highly uncertain and cannot be predicted with confidence, including ~~the severity and~~ the duration of the outbreak, new information that may emerge concerning the ~~efficacy of ongoing global vaccination efforts, potential future recurrences~~severity of the ~~outbreak,~~

COVID-19

pandemic, such as new strains of the ~~spread~~virus,

28

Table of ~~disease~~Contents

including the Delta and Omicron variants and any future variants that may ~~be resistant~~emerge, which may impact rates of infection and vaccination efforts, developments or perceptions regarding the safety of vaccines and the extent and effectiveness of actions to contain the

COVID-19

pandemic or treat its impact, including vaccination campaigns and lockdown measures, among others. In addition, recurrences or additional waves of

COVID-19

cases could cause other widespread or more severe impacts depending on where infection rates are highest. We cannot presently predict the ~~existing vaccines, further containment actions that may be taken by governmental authorities, the impact to the businesses~~scope and severity of any potential business shutdowns or disruptions, but if we or any of our customers and suppliers were to experience prolonged business shutdowns or other disruptions, our ability to conduct our business could be materially and ~~other factors.~~negatively affected, which could have a material adverse impact on our business, results of operations and financial condition.

We continue to closely monitor and evaluate the nature and scope of the impact of the

COVID-19

pandemic to our business, consolidated results of operations, and financial condition, and may take further actions altering our business operations and managing our costs and liquidity that we deem necessary or appropriate to respond to this ~~fast moving~~ongoing and uncertain global health crisis and the resulting global economic consequences.

~~Global Semiconductor Chip Shortage~~

Recent sharp increases in demand for semiconductor products have resulted in a global shortage of manufacturing capacity. As a result, we may experience increased costs to manufacture our products and may not be able to manufacture and deliver all of the orders placed by our customers. Specifically, if we are unable to secure manufacturing capacity from the external foundries we rely on, our ability to deliver products to our customers may be negatively impacted. Also, this shortage of manufacturing capacity may lead to an increase in our manufacturing costs which we may not be fully able to pass on to our customers.

30

~~Table of Contents~~

In an effort to minimize the potential adverse impact of the supply shortage, we are working strategically with external foundries to secure long-term wafer capacity. If we are unsuccessful, however, such shortage could limit our ability to meet demand for our products in the future, which would adversely affect our reputation and competitive position, resulting in a negative impact on results of operations.

We are not able to foresee when the current shortage of manufacturing capacity will subside. A prolonged global supply shortage could negatively impact our financial condition, potentially resulting in a need for additional capital to fund strategic initiatives or operating activities.

3129

Table of Contents

Explanation and Reconciliation of

Non-U.S. GAAP

Measures

Adjusted EBITDA, Adjusted Operating Income and Adjusted Net Income

We use the terms Adjusted EBITDA, Adjusted Operating Income and Adjusted Net Income (including on a per share basis) in this Report. Adjusted EBITDA, as we define it, is a

non-U.S.

GAAP measure. We define Adjusted EBITDA for the periods indicated as EBITDA (as defined below), adjusted to exclude (i) equity-based compensation expense, (ii) foreign currency loss, ~~(gain),~~ net, (iii) derivative valuation loss, ~~(gain),~~ net, (iv) merger-related costs and ~~(iv)~~(v) other charges. EBITDA for the periods indicated is defined as ~~loss from continuing operations~~net income (loss) before interest expense (income), net, income tax expense, and depreciation and amortization.

See the footnotes to the table below for further information regarding these items. We present Adjusted EBITDA as a supplemental measure of our performance because:

we believe that Adjusted EBITDA, by eliminating the impact of a number of items that we do not consider to be indicative of our core ongoing operating performance, provides a more comparable measure of our operating performance from

period-to-period

and may be a better indicator of future performance;

we believe that Adjusted EBITDA is commonly requested and used by securities analysts, investors and other interested parties in the evaluation of ~~the Company~~a company as an enterprise level performance measure that eliminates the effects of financing, income taxes and the accounting effects of capital spending, as well as other one time or recurring items described above; and

we believe that Adjusted EBITDA is useful for investors, among other reasons, to assess ~~the Company’s~~a company’s

period-to-period

core operating performance and to understand and assess the manner in which management analyzes operating performance.

We use Adjusted EBITDA in a number of ways, including:

for planning purposes, including the preparation of our annual operating budget;

to evaluate the effectiveness of our enterprise level business strategies;

in communications with our Board of Directors concerning our consolidated financial performance; and

in certain of our compensation plans as a performance measure for determining incentive compensation payments.

We encourage you to evaluate each adjustment and the reasons we consider them appropriate. In evaluating Adjusted EBITDA, you should be aware that in the future we may incur expenses similar to the adjustments in this presentation. Adjusted EBITDA is not a measure defined in accordance with U.S. GAAP and should not be construed as an alternative to income from continuing operations, cash flows from operating activities or net income, as determined in accordance with U.S. GAAP. A reconciliation of ~~loss from continuing operations~~net income (loss) to Adjusted EBITDA ~~from continuing operations~~ is as follows:


	Three Months Ended June 30, 2021			Six Months Ended June 30, 2021			Three Months Ended June 30, 2020			Six Months Ended June 30, 2020			Three Months Ended March 31, 2022			Three Months Ended March 31, 2021
	(In millions)												(Dollars in millions)
Income (loss) from continuing operations	$	(0.2	)	$	(7.7	)	$	11.8		$	(19.3	)
Net Income (loss)													$	9.5		$	(7.5	)
Interest expense (income), net		(0.5	)		(0.1	)		4.7			9.7			(0.6	)		0.4
Income tax expenses		2.6			2.9			0.7			2.0
Income tax expense														3.5			0.3
Depreciation and amortization		3.5			7.0			2.5			5.1			3.9			3.4

EBITDA	$	5.5		$	2.1		$	19.7		$	(2.5	)		16.3			(3.3	)
Adjustments:
Equity-based compensation expense(a)		2.4			4.1			1.5			2.3			1.6			1.6
Foreign currency loss (gain), net(b)		(0.2	)		4.4			(8.5	)		22.5
Derivative valuation loss (gain), net(c)		0.1			0.1			(0.1	)		(0.2	)
Foreign currency loss, net(b)														0.7			4.7
Derivative valuation loss, net(c)														0.1			0.1
Merger-related costs(d)														—			9.8
Other charges~~(d)~~(e)		5.0			15.4			—			0.6			—			0.6

Adjusted EBITDA	$	12.7		$	26.2		$	12.7		$	22.6		$	18.8		$	13.5

3230

Table of Contents

(a)

This adjustment eliminates the impact of

non-cash

equity-based compensation expenses. Although we expect to incur

non-cash

equity-based compensation expenses in the future, these expenses do not generally require cash settlement, and, therefore, are not used by us to assess the profitability of our operations. We believe that analysts and investors will find it helpful to review our operating performance without the effects of these

non-cash

expenses as supplemental information.

(b)

This adjustment mainly eliminates the impact of

non-cash

foreign currency translation associated with intercompany debt obligations and foreign currency denominated receivables and payables, as well as the cash impact of foreign currency transaction gains or losses on collection of such receivables and payment of such payables. Although we expect to incur foreign currency translation gains or losses in the future, we believe that analysts and investors will find it helpful to review our operating performance without the effects of these primarily

non-cash

gains or losses, which we cannot control. Additionally, we believe the isolation of this adjustment provides investors with enhanced comparability to prior and future periods of our operating performance results.

(c)

This adjustment eliminates the impact of gain or loss recognized in income on derivatives, which represents derivatives value changes excluded from the risk being hedged. We enter into derivative transactions to mitigate foreign exchange risks. As our derivative transactions are limited to a certain portion of our expected cash flows denominated in U.S. dollars, and we do not enter into derivative transactions for trading or speculative purposes, we do not believe that these charges or gains are indicative of our core operating performance.

(d)

For the three ~~and six~~ months ended ~~June 30,~~March 31, 2021, this adjustment eliminates $9.8 million in

non-recurring

professional service fees and expenses incurred in connection with the contemplated Merger ~~and regulatory requests. For the six months ended June 30, 2020,~~transaction (see “Note 16. Merger Agreement” to our consolidated financial statements under “Item 1. Interim Consolidated Financial Statements”). As this adjustment ~~eliminates~~

~~non-recurring~~

~~professional service fees and expenses incurred in connection with certain treasury and finance initiatives. As these expenses~~ meaningfully impacted our operating results and are not expected to represent an ongoing operating expense or income to us, we believe our operating performance results are more usefully compared if ~~these~~this adjustment is excluded.

(e)

For the three months ended March 31, 2021, this adjustment eliminates $0.6 million

non-recurring

professional service fees and expenses incurred in connection with the regulatory requests. As this adjustment meaningfully impacted our operating results and are not expected to represent an ongoing operating expense or income to us, we believe our operating performance results are more usefully compared if this adjustment is excluded.

Adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation, or as a substitute for analysis of our results as reported under U.S. GAAP. Some of these limitations are:

Adjusted EBITDA does not reflect our cash expenditures, or future requirements, for capital expenditures or contractual commitments;

Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;

Adjusted EBITDA does not reflect the interest expense, or the cash requirements necessary to service interest or principal payments, on our debt;

although depreciation and amortization are

non-cash

charges, the assets being depreciated and amortized will often need to be replaced in the future, and Adjusted EBITDA does not reflect any cash requirements for such replacements;

Adjusted EBITDA does not consider the potentially dilutive impact of issuing equity-based compensation to our management team and employees;

Adjusted EBITDA does not reflect the costs of holding certain assets and liabilities in foreign currencies; and

other companies in our industry may calculate Adjusted EBITDA differently than we do, limiting its usefulness as a comparative measure.

Because of these limitations, Adjusted EBITDA should not be considered as a measure of discretionary cash available to us to invest in the growth of our business. We compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted EBITDA only supplementally.

3331

Table of Contents

We present Adjusted Operating Income as supplemental measures of our performance. We prepare Adjusted Operating Income by adjusting operating income (loss) to eliminate the impact of equity-based compensation expenses and other items that may be either one time or recurring that we do not consider to be indicative of our core ongoing operating performance. We believe that Adjusted Operating Income is useful to investors to provide a supplemental way to understand our underlying operating performance and allows investors to monitor and understand changes in our ability to generate income from ongoing business operations.

Adjusted Operating Income is not a measure defined in accordance with U.S. GAAP and should not be construed as an alternative to operating income, income from continuing operations, cash flows from operating activities or net income, as determined in accordance with U.S. GAAP. We encourage you to evaluate each adjustment and the reasons we consider them appropriate. Other companies in our industry may calculate Adjusted Operating Income differently than we do, limiting its usefulness as a comparative measure. In addition, in evaluating Adjusted Operating Income, you should be aware that in the future we may incur expenses similar to the adjustments in this presentation. We define Adjusted Operating Income for the periods indicated as operating income adjusted to exclude (i) equity-based compensation expense, (ii) merger-related costs and ~~(ii)~~(iii) other charges.

The following table summarizes the adjustments to operating income (loss) that we make in order to calculate Adjusted Operating Income ~~from continuing operations~~ for the periods indicated:


	Three Months Ended June 30, 2021		Six Months Ended June 30, 2021			Three Months Ended June 30, 2020		Six Months Ended June 30, 2020		Three Months Ended March 31, 2022		Three Months Ended March 31, 2021
	(In millions)									(Dollars in millions)
Operating income (loss)	$	1.6	$	(0.5	)	$	8.6	$	14.6	$	12.9	$	(2.1	)
Adjustments:
Equity-based compensation expense(a)		2.4		4.1			1.5		2.3		1.6		1.6
Others charges(b)		5.0		15.4			—		0.6
Merger-related costs(b)											—		9.8
Other charges(c)											—		0.6

Adjusted Operating Income	$	9.1	$	19.0		$	10.1	$	17.4	$	14.5	$	10.0

(a)

This adjustment eliminates the impact of

non-cash

equity-based compensation expenses. Although we expect to incur

non-cash

equity-based compensation expenses in the future, these expenses do not generally require cash settlement, and, therefore, are not used by us to assess the profitability of our operations. We believe that analysts and investors will find it helpful to review our operating performance without the effects of these

non-cash

expenses as supplemental information.

(b)

For the three ~~and six~~ months ended ~~June 30,~~March 31, 2021, this adjustment eliminates $9.8 million

non-recurring

professional service fees and expenses incurred in connection with the contemplated Merger ~~and regulatory requests. For the six months ended June 30, 2020,~~transaction (see “Note 16. Merger Agreement” to our consolidated financial statements under “Item 1. Interim Consolidated Financial Statements”). As this adjustment ~~eliminates~~

~~non-recurring~~

~~professional service fees and expenses incurred in connection with certain treasury and finance initiatives. As these expenses~~ meaningfully impacted our operating results and are not expected to represent an ongoing operating expense or income to us, we believe our operating performance results are more usefully compared if ~~these~~this adjustment is excluded.

(c)

For the three months ended March 31, 2021, this adjustment eliminates $0.6 million

non-recurring

professional service fees and expenses incurred in connection with the regulatory requests. As this adjustment meaningfully impacted our operating results and are not expected to represent an ongoing operating expense or income to us, we believe our operating performance results are more usefully compared if this adjustment is excluded.

3432

Table of Contents

We present Adjusted Net Income (including on a per share basis) as a further supplemental measure of our performance. We prepare Adjusted Net Income (including on a per share basis) by adjusting ~~loss from continuing operations~~net income (loss) to eliminate the impact of a number of

non-cash

expenses and other items that may be either one time or recurring that we do not consider to be indicative of our core ongoing operating performance. We believe that Adjusted Net Income (including on a per share basis) is particularly useful because it reflects the impact of our asset base and capital structure on our operating performance. We present Adjusted Net Income (including on a per share basis) for a number of reasons, including:

we use Adjusted Net Income (including on a per share basis) in communications with our Board of Directors concerning our consolidated financial performance without the impact of

non-cash

expenses and the other items as we discussed below since we believe that it is a more consistent measure of our core operating results from period to period; and

we believe that reporting Adjusted Net Income (including on a per share basis) is useful to readers in evaluating our core operating results because it eliminates the effects of

non-cash

expenses as well as the other items we discuss below, such as foreign currency gains and losses, which are out of our control and can vary significantly from period to period.

Adjusted Net Income (including on a per share basis) is not a measure defined in accordance with U.S. GAAP and should not be construed as an alternative to income from continuing operations, cash flows from operating activities or net income, as determined in accordance with U.S. GAAP. We encourage you to evaluate each adjustment and the reasons we consider them appropriate. Other companies in our industry may calculate Adjusted Net Income (including on a per share basis) differently than we do, limiting its usefulness as a comparative measure. In addition, in evaluating Adjusted Net Income (including on a per share basis), you should be aware that in the future we may incur expenses similar to the adjustments in this presentation. We define Adjusted Net Income (including on a per share basis); for the periods indicated as net income (loss) ~~from continuing operations,~~, adjusted to exclude (i) equity-based compensation expense, (ii) foreign currency loss, ~~(gain),~~ net, (iii) derivative valuation loss, ~~(gain),~~ net, (iv) merger-related costs, (v) other charges and ~~(v)~~(vi) income tax effect on

non-GAAP

adjustments.

The following table summarizes the adjustments to net income (loss) ~~from continuing operations~~ that we make in order to calculate Adjusted Net Income (including on a per share basis) ~~from continuing operations~~ for the periods indicated:

Three Months
Ended
June 30,
2021

Six Months
Ended
June 30,
2021

Three Months
Ended
June 30,
2020

Six Months
Ended
June 30,
2020


(In millions)

Income (loss) from continuing operations
   $ (0.2 )    $ (7.7 )    $ 11.8    $ (19.3 )
Adjustments:

Equity-based compensation expense(a)
   2.4    4.1    1.5    2.3
Foreign currency loss (gain), net(b)
   (0.2 )    4.4    (8.5 )    22.5
Derivative valuation loss (gain), net(c)
   0.1    0.1    (0.1 )    (0.2 )
Other charges(d)
   5.0    15.4    —      0.6
Income tax effect on
non-GAAP
adjustments(e)
   —      —      —      —








Adjusted Net Income
   $ 7.0    $ 16.4    $ 4.8    $ 5.8








Reported earnings (loss) per share – basic
   $ (0.00 )    $ (0.18 )    $ 0.34    $ (0.55 )
Reported earnings (loss) per share – diluted
   $ (0.00 )    $ (0.18 )    $ 0.28    $ (0.55 )
Weighted average number of shares – basic
   46,322,027    43,324,088    35,092,312    34,992,734
Weighted average number of shares – diluted
   46,322,027    43,324,088    46,474,237    34,992,734
Adjusted earnings per share – basic
   $ 0.15    $ 0.38    $ 0.14    $ 0.17
Adjusted earnings per share – diluted
   $ 0.15    $ 0.36    $ 0.13    $ 0.16
Weighted average number of shares – basic
   46,322,027    43,324,088    35,092,312    34,992,734
Weighted average number of shares – diluted
   47,846,217    47,685,875    36,330,083    36,248,039


	Three Months Ended March 31, 2022		Three Months Ended March 31, 2021
	(Dollars in millions, except per share data)
Net Income (Loss)	$	9.5	$	(7.5	)
Adjustments:
Equity-based compensation expense(a)		1.6		1.6
Foreign currency loss, net(b)		0.7		4.7
Derivative valuation loss, net(c)		0.1		0.1
Merger-related costs(d)		—		9.8
Other charges(e)		—		0.6
Income tax effect on non-GAAP adjustments(f)		1.0		—

Adjusted Net Income	$	12.9	$	9.3

Reported earnings (loss) per share—basic	$	0.21	$	(0.19	)
Reported earnings (loss) per share—diluted	$	0.20	$	(0.19	)
Weighted average number of shares—basic		45,603,208		40,292,838
Weighted average number of shares—diluted		46,693,294		40,292,838
Adjusted earnings per share—basic	$	0.28	$	0.23
Adjusted earnings per share—diluted	$	0.28	$	0.22
Weighted average number of shares—basic		45,603,208		40,292,838
Weighted average number of shares—diluted		46,693,294		47,470,416

(a)

This adjustment eliminates the impact of

non-cash

equity-based compensation expenses. Although we expect to incur

non-cash

equity-based compensation expenses in the future, these expenses do not generally require cash settlement, and, therefore, are not used by us to assess the profitability of our operations. We believe that analysts and investors will find it helpful to review our operating performance without the effects of these

non-cash

expenses as supplemental information.

(b)

This adjustment mainly eliminates the impact of

non-cash

foreign currency translation associated with intercompany debt obligations and foreign currency denominated receivables and payables, as well as the cash impact of foreign currency transaction gains or losses on collection of such receivables and payment of such payables. Although we expect to incur foreign currency translation gains or losses in the future, we believe that analysts and investors will find it helpful to review our operating performance without the effects of these primarily

non-cash

gains or losses, which we cannot control. Additionally, we believe the isolation of this adjustment provides investors with enhanced comparability to prior and future periods of our operating performance results.

3533

Table of Contents

(c)

This adjustment eliminates the impact of gain or loss recognized in income on derivatives, which represents derivatives value changes excluded from the risk being hedged. We enter into derivative transactions to mitigate foreign exchange risks. As our derivative transactions are limited to a certain portion of our expected cash flows denominated in U.S. dollars, and we do not enter into derivative transactions for trading or speculative purposes, we do not believe that these charges or gains are indicative of our core operating performance.

(d)

For the three ~~and six~~ months ended ~~June 30,~~March 31, 2021, this adjustment eliminates $9.8 million

non-recurring

professional service fees and expenses incurred in connection with the contemplated Merger ~~and regulatory requests. For the six months ended June 30, 2020,~~transaction (see “Note 16. Merger Agreement” to our consolidated financial statements under “Item 1. Interim Consolidated Financial Statements”). As this adjustment ~~eliminates~~

~~non-recurring~~

~~professional service fees and expenses incurred in connection with certain treasury and finance initiatives. As these expenses~~ meaningfully impacted our operating results and are not expected to represent an ongoing operating expense or income to us, we believe our operating performance results are more usefully compared if ~~these expenses are~~this adjustment is excluded.

(e)

For the three months ended March 31, 2021, this adjustment eliminates $0.6 million

non-recurring

professional service fees and expenses incurred in connection with the regulatory requests. As this adjustment meaningfully impacted our operating results and are not expected to represent an ongoing operating expense or income to us, we believe our operating performance results are more usefully compared if this adjustment is excluded.

(f)

For the three ~~and six~~ months ended ~~June 30, 2021~~March 31, 2022, this adjustment eliminates the income tax effect on

non-GAAP

adjustments of $1.0 million related to our Korean subsidiary using a calculation method that we compare the tax expense of our Korean subsidiary with and ~~2020, there was no tax impact from~~without the adjustments to net income to calculate our Adjusted Net Income due to net operating loss carry-forwards available at our parent entity in the U.S., based on the nature and origination of the adjustments, to offset related taxable income.

non-GAAP

adjustments.

We believe that all adjustments to ~~loss from continuing operations~~net income (loss) used to calculate Adjusted Net Income was applied consistently to the periods presented.

Adjusted Net Income has limitations as an analytical tool, and you should not consider it in isolation, or as a substitute for analysis of our results as reported under U.S. GAAP. Some of these limitations are:

Adjusted Net Income does not reflect changes in, or cash requirements for, our working capital needs;

Adjusted Net Income does not consider the potentially dilutive impact of issuing equity-based compensation to our management team and employees;

Adjusted Net Income does not reflect the costs of holding certain assets and liabilities in foreign currencies; and

other companies in our industry may calculate Adjusted Net Income differently than we do, limiting its usefulness as a comparative measure.

Because of these limitations, Adjusted Net Income should not be considered as a measure of profitability of our business. We compensate for these limitations by relying primarily on our U.S. GAAP results and using Adjusted Net Income only as a supplement.

3634

Table of Contents

Factors Affecting Our Results of Operations

Net

Sales.

We derive substantially all of our sales (net of sales returns and allowances) from our standard products business. We outsource manufacturing of mobile OLED products to external

12-inch

foundries. Our product inventory is primarily located in Korea and is available for drop shipment globally. Outside of Korea, we maintain limited product inventory, and our sales representatives generally relay orders to our factories in Korea for fulfillment. We have strategically located our sales offices near concentrations of major customers. Our sales offices are located in Korea, Japan, Taiwan and Greater China. Our network of authorized agents and distributors is in the United States, Europe and the Asia Pacific region.

We recognize revenue when a customer obtains control of the product, which is generally upon product shipment, delivery at the customer’s location or upon customer acceptance, depending on the terms of the arrangement. For the ~~six~~three months ended ~~June 30,~~March 31, 2022 and 2021, ~~and 2020,~~ we sold products to ~~165~~140 and ~~158~~145 customers, respectively, and our net sales to our ten largest customers represented ~~81%~~72% and ~~89%~~82% of our net sales—standard products business, respectively.

We will provide the Transitional Fab 3 Foundry Services up to September 1, 2023 at an agreed upon cost plus a

mark-up.

For the periods prior to the closing of the sale of the Foundry Services Group business and Fab 4 as of September 1, 2020 (which are accounted for as discontinued operations beginning in the first quarter of 2020), revenue derived from the Transitional Fab 3 Foundry Services is recorded at cost in both our continuing and discontinued operations.

Gross Profit.

Our overall gross profit generally fluctuates as a result of changes in overall sales volumes and in the average selling prices of our products and services. Other factors that influence our gross profit include changes in product mix, the introduction of new products and services and subsequent generations of existing products and services, shifts in the utilization of our manufacturing facility and the yields achieved by our manufacturing operations, changes in material, labor and other manufacturing costs including outsourced manufacturing expenses, and variation in depreciation expense.

Average

Selling

Prices.

Average selling prices for our products tend to be highest at the time of introduction of new products which utilize the latest technology and tend to decrease over time as such products mature in the market and are replaced by next generation products. We strive to offset the impact of declining selling prices for existing products through our product development activities and by introducing new products that command selling prices above the average selling price of our existing products. In addition, we seek to manage our inventories and manufacturing capacity so as to preclude losses from product and productive capacity obsolescence.

Material Costs.

Our material costs consist of costs of raw materials, such as silicon wafers, chemicals, gases and tape and packaging supplies. We use processes that require specialized raw materials, such as silicon wafers, that are generally available from a limited number of suppliers. If demand increases or supplies decrease, the costs of our raw materials could increase significantly.

Labor

Costs.

A significant portion of our employees are located in Korea. Under Korean labor laws, most employees and certain executive officers with one or more years of service are entitled to severance benefits upon the termination of their employment based on their length of service and rate of pay. As of ~~June 30, 2021,~~March 31, 2022, approximately 98% of our employees were eligible for severance benefits.

Depreciation Expense.

We periodically evaluate the carrying values of long-lived assets, including property, plant and equipment and intangible assets, as well as the related depreciation periods. We depreciated our property, plant and equipment using the straight-line method over the estimated useful lives of our assets. Depreciation rates vary from

30-40

years on buildings to 5 to 12 years for certain equipment and assets. Our evaluation of carrying values is based on various analyses including cash flow and profitability projections. If our projections indicate that future undiscounted cash flows are not sufficient to recover the carrying values of the related long-lived assets, the carrying value of the assets is impaired and will be reduced, with the reduction charged to expense so that the carrying value is equal to fair value.

Selling

Expenses.

We sell our products worldwide through a direct sales force as well as a network of sales agents and representatives to OEMs, including major branded customers and contract manufacturers, and indirectly through distributors. Selling expenses consist primarily of the personnel costs for the members of our direct sales force, a network of sales representatives and other costs of distribution. Personnel costs include base salary, benefits and incentive compensation.

General

and

Administrative

Expenses.

General and administrative expenses consist of the costs of various corporate operations, including finance, legal, human resources and other administrative functions. These expenses primarily consist of payroll-related expenses, consulting and other professional fees and office facility-related expenses.

37

~~Table of Contents~~

Research

and

Development.

The rapid technological change and product obsolescence that characterize our industry require us to make continuous investments in research and development. Product development time frames vary but, in general, we incur research and development costs one to two years before generating sales from the associated new products. These expenses include personnel costs for members of our engineering workforce, cost of photomasks, silicon wafers and other

non-recurring

engineering charges related to product design. Additionally, we develop base line process technology through experimentation and through the design and use of characterization wafers that help achieve commercially feasible yields for new products. The majority of research

35

Table of Contents

and development expenses of our display business are material and design-related costs for OLED display driver IC product development involving

28-nanometer

or finer processes. The majority of research and development expenses of our power business are certain equipment, material and design-related costs for power discrete products and material and design-related costs for power IC products. Power IC uses standard BCD process technologies which can be sourced from multiple foundries, including Fab 4.

~~Interest Expense.~~

Our interest expense was incurred primarily under our 6.625% Senior Notes due July 15, 2021 (the “2021 Notes”) and the Exchangeable Notes. We redeemed all outstanding 2021 Notes on October 2, 2020. Our Exchangeable Notes were exchanged for common stock prior to their maturity date of March 1, 2021. From and after October 2, 2020 and March 1, 2021, we have not and will not incur interest expense associated with the 2021 Notes and Exchangeable Notes, respectively.

Impact of Foreign Currency Exchange Rates on Reported Results of Operations.

Historically, a portion of our revenues and cost of sales and greater than the majority of our operating expenses ~~and costs of sales~~ have been denominated in

non-U.S.

currencies, principally the Korean won, and we expect that this will remain true in the future. Because we report our results of operations in U.S. dollars converted from our

non-U.S.

revenues and expenses based on monthly average exchange rates, changes in the exchange rate between the Korean won and the U.S. dollar could materially impact our reported results of operations and distort period to period comparisons. In particular, because of the difference in the amount of our consolidated revenues and expenses that are in U.S. dollars relative to Korean won, depreciation in the U.S. dollar relative to the Korean won could result in a material increase in reported costs relative to revenues, and therefore could cause our profit margins and operating income to appear to decline materially, particularly relative to prior periods. The converse is true if the U.S. dollar were to appreciate relative to the Korean won. Moreover, our foreign currency gain or loss would be affected by changes in the exchange rate between the Korean won and the U.S. dollar as a substantial portion of

non-cash

translation gain or loss is associated with the intercompany long-term loans to our Korean subsidiary, which is denominated in U.S. dollars. As of ~~June 30, 2021,~~March 31, 2022, the outstanding intercompany loan balance including accrued interest between our Korean subsidiary and our Dutch subsidiary was ~~$387.5~~$348.5 million. As a result of such foreign currency fluctuations, it could be more difficult to detect underlying trends in our business and results of operations. In addition, to the extent that fluctuations in currency exchange rates cause our results of operations to differ from our expectations or the expectations of our investors, the trading price of our stock could be adversely affected.

From time to time, we may engage in exchange rate hedging activities in an effort to mitigate the impact of exchange rate fluctuations. Our Korean subsidiary enters into foreign currency zero cost collar contracts in order to mitigate a portion of the impact of U.S. dollar-Korean won exchange rate fluctuations on our operating results. Obligations under these foreign currency zero cost collar contracts must be cash collateralized if our exposure exceeds certain specified thresholds. These zero cost collar contracts may be terminated by a counterparty in a number of circumstances, including if our ~~credit rating falls below~~

~~B-/B3~~

~~or if our~~ total cash and cash equivalents is less than $30.0 million at the end of a fiscal quarter unless a waiver is obtained from the counterparty. We cannot assure that any hedging technique we implement will be effective. If our hedging activities are not effective, changes in currency exchange rates may have a more significant impact on our results of operations.

Foreign Currency Gain or Loss.

Foreign currency translation gains or losses on transactions by us or our subsidiaries in a currency other than our or our subsidiaries’ functional currency are included in foreign currency gain (loss), net in our statements of operations. A substantial portion of this net foreign currency gain or loss relates to

non-cash

translation gain or loss related to the principal balance of intercompany balances at our Korean subsidiary that are denominated in U.S. dollars. This gain or loss results from fluctuations in the exchange rate between the Korean won and U.S. dollar.

Income Taxes.

We record our income taxes in each of the tax jurisdictions in which we operate. This process involves using an asset and liability approach whereby deferred tax assets and liabilities are recorded for differences in the financial reporting bases and tax basis of our assets and liabilities. We exercise significant management judgment in determining our provision for income taxes, deferred tax assets and liabilities. We assess whether it is more likely than not that the deferred tax assets existing at the

period-end

will be realized in future periods. In such assessment, we consider all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent results of operations. In the event we were to determine that we would be able to realize the deferred income tax assets in the future in excess of their net recorded amount, we would adjust the valuation allowance, which would reduce the provision for income taxes.

We are subject to income- or

non-income-based

tax examinations by tax authorities of the U.S., Korea and multiple other foreign jurisdictions for all open tax years. Significant estimates and judgments are required in determining our worldwide provision for income- or

non-income

based taxes. Some of these estimates are based on interpretations of existing tax laws or regulations. The ultimate amount of tax liability may be uncertain as a result.

38

~~Table of Contents~~

~~Discontinued Operations.~~

On March 30, 2020, we entered into the Business Transfer Agreement for the sale of our Foundry Services Group business and Fab 4 to the Buyer. As a result, the results of the Foundry Services Group business were classified as discontinued operations in our consolidated statements of operations and excluded from both continuing operations and segment results for all periods presented. On September 1, 2020, we completed the sale for a purchase price of approximately $350.6 million in cash.

Capital

Expenditures.

We primarily invest in manufacturing equipment, software design tools and other tangible assets mainly for fabrication facility maintenance, capacity expansion and technology improvement. Capacity expansions and technology improvements typically occur in anticipation of increases in demand. We typically pay for capital expenditures in partial installments with portions due on order, delivery and final acceptance. Our capital expenditures mainly include our payments for the purchase of property, plant and equipment.

36

Table of Contents

Inventories.

We monitor our inventory levels in light of product development changes and market expectations. We may be required to take additional charges for quantities in excess of demand, cost in excess of market value and product age. Our analysis may take into consideration historical usage, expected demand, anticipated sales price, new product development schedules, the effect new products might have on the sales of existing products, product age, customer design activity, customer concentration and other factors. These forecasts require us to estimate our ability to predict demand for current and future products and compare those estimates with our current inventory levels and inventory purchase commitments. Our forecasts for our inventory may differ from actual inventory use.

3937

Table of Contents

Results of Operations – Comparison of Three Months Ended ~~June 30,~~March 31, 2022 and 2021 ~~and 2020~~

The following table sets forth consolidated results of operations for the three months ended ~~June 30, 2021~~March 31, 2022 and ~~2020:~~2021:

Three Months Ended
June 30, 2021

Three Months Ended
June 30, 2020


Amount

% of
Total revenues

Amount

% of
Total revenues

Change
Amount


(In millions)

Revenues

Net sales – standard products business
   $ 103.3 90.7 % $ 109.0 91.7 % $ (5.7 )
Net sales – transitional Fab 3 foundry services
   10.6 9.3 9.9 8.3 0.7


Total revenues
   113.9 100.0 118.8 100.0 (5.0 )
Cost of sales

Cost of sales – standard products business
   70.4 61.8 76.8 64.6 (6.4 )
Cost of sales – transitional Fab 3 foundry services
   9.5 8.3 9.9 8.3 (0.4 )


Total cost of sales
   79.9 70.2 86.7 73.0 (6.8 )


Gross profit
   34.0 29.8 32.1 27.0 1.8
Selling, general and administrative expenses
   14.0 12.3 12.4 10.4 1.6
Research and development expenses
   13.3 11.7 11.1 9.3 2.2
Other charges
   5.0 4.4 —   —   5.0


Operating income
   1.6 1.4 8.6 7.3 (7.0 )
Interest expense
   (0.1 ) (0.1 ) (5.4 ) (4.6 ) 5.3
Foreign currency gain, net
   0.3 0.2 8.5 7.1 (8.2 )
Others, net
   0.6 0.5 0.8 0.7 (0.2 )


   0.8 0.7 3.8 3.2 (3.1 )


Income from continuing operations before income tax expense
   2.4 2.1 12.5 10.5 (10.0 )
Income tax expense
   2.6 2.3 0.7 0.6 1.9


Income (loss) from continuing operations
   (0.2 ) (0.2 ) 11.8 9.9 (12.0 )
Income from discontinued operations, net of tax
   —   —   17.4 14.6 (17.4 )


Net income (loss)
   $ (0.2 ) (0.2 ) $ 29.2 24.5 $ (29.4 )


	Three Months Ended March 31, 2022						Three Months Ended March 31, 2021
	Amount			% of Total Revenues			Amount			% of Total Revenues			Change Amount
	(Dollars in millions)
Revenues
Net sales – standard products business	$	94.0			90.3	%	$	112.9			91.8	%	$	(18.9	)
Net sales – transitional Fab 3 foundry services		10.1			9.7			10.1			8.2			(0.0	)

Total revenues		104.1			100.0			123.0			100.0			(18.9	)
Cost of sales
Cost of sales – standard products business		56.1			53.9			79.2			64.4			(23.2	)
Cost of sales – transitional Fab 3 foundry services		9.0			8.7			9.4			7.6			(0.4	)

Total cost of sales		65.1			62.5			88.6			72.1			(23.5	)

Gross profit		39.0			37.5			34.4			27.9			4.6

Selling, general and administrative expenses		14.2			13.6			12.6			10.3			1.5
Research and development expenses		12.0			11.5			13.4			10.9			(1.5	)
Merger-related costs		—			—			9.8			8.0			(9.8	)
Other charges		—			—			0.6			0.5			(0.6	)

Operating income (loss)		12.9			12.4			(2.1	)		(1.7	)		15.0

Interest expense		(0.1	)		(0.1	)		(1.0	)		(0.8	)		0.9
Foreign currency loss, net		(0.7	)		(0.7	)		(4.7	)		(3.8	)		4.0
Others, net		0.9			0.9			0.6			0.5			0.3

		0.1			0.1			(5.1	)		(4.1	)		5.2

Income (loss) before income tax expense		13.0			12.5			(7.2	)		(5.8	)		20.2
Income tax expense		3.5			3.3			0.3			0.2			3.2

Net income (loss)	$	9.5			9.2		$	(7.5	)		(6.1	)	$	17.0


	Three Months Ended March 31, 2022					Three Months Ended March 31, 2021
	Amount		% of Total Revenues			Amount		% of Total Revenues			Change Amount
	(Dollars in millions)
Revenues
Net sales – standard products business
Display Solutions	$	29.2		28.0	%	$	58.9		47.9	%	$	(29.7	)
Power Solutions		64.8		62.3			54.0		43.9			10.8

Total standard products business		94.0		90.3			112.9		91.8			(18.9	)
Net sales – transitional Fab 3 foundry services		10.1		9.7			10.1		8.2			(0.0	)

Total revenues	$	104.1		100.0	%	$	123.0		100.0	%	$	(18.9	)


	Three Months Ended March 31, 2022					Three Months Ended March 31, 2021
	Amount		% of Net Sales			Amount		% of Net Sales			Change Amount
	(Dollars in millions)
Gross Profit
Gross profit – standard products business	$	37.9		40.3	%	$	33.7		29.8	%	$	4.3
Gross profit – transitional Fab 3 foundry services		1.1		10.6			0.7		7.1			0.3

Total gross profit	$	39.0		37.5	%	$	34.4		27.9	%	$	4.6

40

38

Table of Contents

~~The following sets forth information relating to our continuing operations:~~

Three Months Ended
June 30, 2021

Three Months Ended
June 30, 2020


Amount

% of
Total revenues

Amount

% of
Total revenues

Change
Amount


(In millions)

Revenues

Net sales – standard products business

Display Solutions
   $ 46.6    40.9 % $ 69.2    58.2 % $ (22.6 )
Power Solutions
   56.7    49.8 39.8    33.5 16.9






Total standard products business
   103.3    90.7 109.0    91.7 (5.7 )
Net sales – transitional Fab 3 foundry services
   10.6    9.3 9.9    8.3 0.7






Total revenues
   $ 113.9    100.0 % $ 118.8    100.0 % $ (5.0 )

Three Months Ended
June 30, 2021

Three Months Ended
June 30, 2020


Amount

% of
Net sales

Amount

% of
Net sales

Change
Amount


(In millions)

Gross Profit

Gross profit – standard products business
   $ 32.9    31.8 % $ 32.1    29.5 % $ 0.7
Gross profit – transitional Fab 3 foundry services
   1.1    10.5 —      —   1.1






Total gross profit
   $   34.0      29.8 % $   32.1      27.0 % $    1.8

Revenues

Total revenues were ~~$113.9~~$104.1 million for the three months ended ~~June 30, 2021, a $5.0��~~March 31, 2022, an $18.9 million, or ~~4.2%~~15.4%, decrease compared to ~~$118.8~~$123.0 million for the three months ended ~~June 30, 2020.~~March 31, 2021. This decrease was primarily due to a decrease in revenue related to our standard products business as described below.

The standard products business.

Net sales from our standard products business were ~~$103.3~~$94.0 million for the three months ended ~~June 30, 2021, a $5.7~~March 31, 2022, an $18.9 million, or ~~5.2%~~16.7%, decrease compared to ~~$109.0~~$112.9 million for the three months ended ~~June 30, 2020. This~~March 31, 2021. The decrease in net sales from our Display Solutions business line was primarily attributable to a decrease in revenue from our mobile OLED display driver ICs stemming from a continuing ~~global~~severe shortage in manufacturing capacity (in particular for 28nm

12-inch

OLED wafers), as we outsource manufacturing of these products to external

12-inch

~~foundries. This decrease~~foundries, and lower customer demand resulting from a slowdown in the Chinese smartphone market in the first quarter of 2022, which was offset in part by a higher demand for our OLED TV DDIC and

auto-LCD

DDIC. The increase in net sales from our Power Solutions business line was attributable to a strong demand for power products such as MOSFETs, including

high-end

MOSFETs, primarily for TVs, smartphones and

~~e-bikes,~~

~~whereas the revenue~~ industrial applications, and IGBTs mainly for ~~power products in the second quarter of 2020 was impacted by~~

~~COVID-19-related~~

~~supply chain issues and market softness in China.~~solar inverters.

The transitional Fab 3 foundry services.

Net sales from the transitional Fab 3 foundry services were ~~$10.6~~$10.1 million ~~and $9.9 million~~ for each of the three months ended ~~June 30,~~March 31, 2022 and 2021, ~~and 2020,~~ respectively.

Gross Profit

Total gross profit was ~~$34.0~~$39.0 million for the three months ended ~~June 30, 2021~~March 31, 2022 compared to ~~$32.1~~$34.4 million for the three months ended ~~June 30, 2020,~~March 31, 2021, a ~~$1.8~~$4.6 million, or ~~5.7%~~13.4%, increase. Gross profit as a percentage of net sales for the three months ended ~~June 30, 2021~~March 31, 2022 increased to ~~29.8%~~37.5% compared to ~~27.0%~~27.9% for the three months ended ~~June 30, 2020.~~March 31, 2021. The increase in gross profit and gross profit as a percentage of net sales was primarily due to our standard products business as further described below.

The standard products business.

Gross profit from our standard products business was ~~$32.9~~$37.9 million for the three months ended ~~June 30, 2021,~~March 31, 2022, which represented a ~~$0.7~~$4.3 million, or ~~2.2%~~12.7%, increase from gross profit of ~~$32.1~~$33.7 million for the three months ended ~~June 30, 2020.~~March 31, 2021. Gross profit as a percentage of net sales for the three months ended ~~June 30, 2021~~March 31, 2022 increased to ~~31.8%~~40.3% compared to ~~29.5%~~29.8% for the three months ended ~~June 30, 2020.~~March 31, 2021. The increase in both gross profit and gross profit margin was primarily attributable to an improved product mix and ~~a higher utilization rate of our internal fabrication facility~~an increase in ~~Gumi.~~average selling price benefited from the favorable pricing environment.

4139

Table of Contents

Net Sales – Standard Products Business by Geographic Region

We report net sales – standard products business by geographic region based on the location to which the products are billed. The following table sets forth our net sales—standard products business by geographic region and the percentage of total net sales—standard products business represented by each geographic region for the three months ended ~~June 30, 2021~~March 31, 2022 and ~~2020:~~2021:


	Three Months Ended June 30, 2021					Three Months Ended June 30, 2020								Three Months Ended March 31, 2022					Three Months Ended March 31, 2021
	Amount		% of Net sales – standard products business			Amount		% of Net sales – standard products business			Change Amount			Amount		% of Net Sales – standard products business			Amount		% of Net Sales – standard products business			Change Amount
	(In millions)													(Dollars in millions)
Korea	$	30.9		29.9	%	$	22.0		20.2	%	$	8.9		$	31.0		33.0	%	$	26.4		23.4	%	$	4.6
Asia Pacific (other than Korea)		69.4		67.2			84.2		77.3			(14.9	)		58.3		62.0			83.7		74.2			(25.5	)
United States		1.4		1.3			1.5		1.3			(0.1	)		2.9		3.0			1.3		1.1			1.6
Europe		1.2		1.2			0.9		0.8			0.4			1.9		2.0			1.2		1.1			0.6
Others		0.5		0.5			0.5		0.4			0.0			—		—			0.2		0.2			(0.2	)

	$	103.3		100.0	%	$	109.0		100.0	%	$	(5.7	)	$	94.0		100.0	%	$	112.9		100.0	%	$	(18.9	)

Net sales – standard products business in Korea for the three months ended ~~June 30, 2021~~March 31, 2022 increased from ~~$22.0~~$26.4 million to ~~$30.9~~$31.0 million compared to the three months ended ~~June 30, 2020,~~March 31, 2021, or by ~~$8.9~~$4.6 million, or ~~40.6%~~17.4%, primarily due to a ~~higher~~strong demand for power products such as MOSFETs, including

high-end

MOSFETs, primarily for TVTVs and smartphone applications. ~~This increase was offset~~The increased demand for OLED TV DDIC also favorably affected in part by a decrease in revenue related to our mobile OLED display driver ICs stemming from a continuing global shortage in manufacturing capacity, as we outsource manufacturing of these products to external

~~12-inch~~

~~foundries.~~this quarter.

Net sales – standard products business in Asia Pacific (other than Korea) for the three months ended ~~June 30, 2021~~March 31, 2022 decreased to ~~$69.4~~$58.3 million from ~~$84.2~~$83.7 million in the three months ended ~~June 30, 2020,~~March 31, 2021, or by ~~$14.9~~$25.5 million, or ~~17.6%~~30.4%, primarily due to a decrease in revenue from our mobile OLED display driver ICs stemming from a continuing ~~global~~severe shortage in manufacturing capacity (in particular for 28nm

12-inch

OLED wafers), as we outsource manufacturing of these products to external

12-inch

foundries, and lower customer demand resulting from a slowdown in the Chinese smartphone market in the first quarter of 2022, which was offset in part by a higher demand for power products such as MOSFETs, including

high-end

MOSFETs, primarily for TVs, computing and industrial applications, and IGBTs mainly for solar inverters. The increased demand for our

~~e-bikes.~~auto-LCD

DDIC also favorably affected in this quarter.

Operating Expenses

Selling,

General

and

Administrative

Expenses.

Selling, general and administrative expenses were ~~$14.0~~$14.2 million, or ~~12.3%~~13.6% of total revenues, for the three months ended ~~June 30, 2021,~~March 31, 2022, compared to ~~$12.4~~$12.6 million, or ~~10.4%~~10.3% of total revenues, for the three months ended ~~June 30, 2020.~~March 31, 2021. The increase of ~~$1.6~~$1.5 million, or ~~12.8%~~12.1%, was primarily attributable to ~~certain~~

~~non-income-based~~

~~tax assessments of $0.6 million as a result of a regular tax examination completed for our primary operating entity~~an increase in ~~Korea for multiple tax years,~~employee compensation including certain incentive and ~~the grant timing of equity-based compensation. This increase was offset in part by a decrease in professional fees mainly comprised of legal and consulting fees.~~benefit related accruals.

Research

and

Development

Expenses.

Research and development expenses were ~~$13.3~~$12.0 million, or ~~11.7%~~11.5% of total revenues, for the three months ended ~~June 30, 2021,~~March 31, 2022, compared to ~~$11.1~~$13.4 million, or ~~9.3%~~10.9% of total revenues, for the three months ended ~~June 30, 2020.~~March 31, 2021. The ~~increase~~decrease of ~~$2.2~~$1.5 million, or ~~19.9%~~10.9%, was primarily attributable to the timing of development activities for our

28-nanometer

OLED display driver ICs, which was offset in part by an increase in ~~outside service fees and various overhead expenses.~~employee compensation.

~~Other Charges.~~Merger-related Costs.

~~Other charges were $5.0 million for~~For the three months ended ~~June 30,~~March 31, 2021, ~~which consisted~~we recorded $9.8 million of

non-recurring

professional service fees and expenses incurred in connection with the contemplated Merger transaction.

Other Charges.

For the three months ended March 31, 2021, we recorded $0.6 million of

non-recurring

professional service fees and expenses incurred in connection with the regulatory requests.

Operating Income (Loss)

As a result of the foregoing, operating income of $12.9 million was ~~$1.6~~recorded for the three months ended March 31, 2022 compared to operating loss of $2.1 million for the three months ended ~~June 30, 2021 compared to operating income of $8.6 million the three months ended June 30, 2020.~~March 31, 2021. As discussed above, the ~~decrease~~increase in operating income of ~~$7.0~~$15.0 million resulted primarily from a ~~$5.0~~$9.8 million decrease in Merger-related costs, a $4.6 million increase in ~~other charges, $2.2~~gross profit, a $1.5 million ~~increase~~decrease in research and development expenses and a ~~$1.6~~$0.6 million ~~increase~~decrease in ~~selling, general and administrative expenses.~~other charges. This increase was offset in part by a ~~$1.8~~$1.5 million increase in ~~gross profit.~~selling, general and administrative expenses.

4240

Table of Contents

Other Income (Expense)

Interest

Expense.

Interest expenses ~~was~~were $0.1 million and ~~$5.4~~$1.0 million for the three months ended June 30, 2021 and June 30, 2020, respectively. Interest expenses was incurred primarily under our 2021 Notes and Exchangeable Notes. We redeemed all outstanding 2021 Notes on October 2, 2020. Our Exchangeable Notes were exchanged for common stock prior to their maturity date of March ~~1, 2021. From and after October 2, 2020~~31, 2022 and March 1,31, 2021, ~~we have not incurred interest expense associated with the 2021 Notes and Exchangeable Notes, respectively.~~

~~Foreign~~

~~Currency~~

~~Gain,~~

~~Net.~~

Net foreign currency gain for the three months ended June 30, 2021 was $0.3 million compared to net foreign currency gain of $8.5 million for the three months ended June 30, 2020. The net foreign currency gain for the three months ended June 30, 2021 and June 30, 2020 was due to the appreciation in value of the Korean won relative to the U.S. dollar during the period.

~~A substantial portion of our net foreign currency gain or loss is~~

~~non-cash~~

translation gain or loss associated with intercompany long-term loans to our Korean subsidiary, which are denominated in U.S. dollars, and are affected by changes in the exchange rate between the Korean won and the U.S. dollar. As of June 30, 2021 and June 30, 2020, the outstanding intercompany loan balances, including accrued interest between our Korean subsidiary and our Dutch subsidiary, were $387 million and $691 million, respectively. Foreign currency translation gain or loss from intercompany balances were included in determining our consolidated net income since the intercompany balances were not considered long-term investments in nature because management intended to settle these intercompany balances at their respective maturity dates.

~~Others,~~

~~Net.~~

Others were comprised of rental income, interest income, and gains and losses from valuation of derivatives which were designated as hedging instruments. Others for the three months ended June 30, 2021 and June 30, 2020 was $0.6 million and $0.8 million, respectively.

~~Income Tax Expense~~

Income tax expense was $2.6 million for the three months ended June 30, 2021, which was primarily attributable to interest on intercompany loan balances and certain income-based tax assessments of $0.6 million as a result of a regular tax examination completed for our Korean subsidiary for multiple tax years. Income tax expense was $0.7 million for the three months ended June 30, 2020, which was primarily attributable to interest on intercompany loan balances and the estimated taxable income for our Korean subsidiary, combined with its ability to utilize net operating loss carryforwards up to 60%.

~~Income (Loss) from Continuing Operations~~

As a result of the foregoing, income from continuing operations decreased by $12.0 million for the three months ended June 30, 2021 compared to the three months ended June 30, 2020. As discussed above, the decrease in income from continuing operations primarily resulted from an $8.2 million decrease in net foreign currency gain and a $7.0 million decrease in operating income, which were offset in part by a $5.3 million decrease in interest expense.

~~Income from Discontinued Operations, Net of Tax~~

On March 30, 2020, we entered into the Business Transfer Agreement for the sale of our Foundry Services Group business and Fab 4. As a result, the results of the Foundry Services Group business were classified as discontinued operations in our consolidated statements of operations and excluded from our continuing operations for all periods presented. Income from discontinued operations, net of tax was $17.4 million for the three months ended June 30, 2020. On September 1, 2020, we completed the sale of our Foundry Services Group business and Fab 4 for a purchase price equal to approximately $350.6 million in cash. We have not incurred a gain or loss from discontinued operations in 2021 as the sale of the Foundry Service Group business and Fab 4 was completed in 2020.

~~Net Income (Loss)~~

As a result of the foregoing, a net loss of $0.2 million was recorded for the three months ended June 30, 2021 compared to a net income of $29.2 million for the three months ended June 30, 2020. As discussed above, the decrease in net income of $29.4 million primarily resulted from a $17.4 million decrease in income from discontinued operations, net of tax and a $12.0 million decrease in income from continuing operations.

43

~~Table of Contents~~

~~Results of Operations – Comparison of Six Months Ended June 30, 2021 and 2020~~

~~The following table sets forth consolidated results of operations for the six months ended June 30, 2021 and 2020:~~

Six Months Ended
June 30, 2021

Six Months Ended
June 30, 2020


Amount

% of
Total revenues

Amount

% of
Total revenues

Change
Amount


(In millions)

Revenues

Net sales – standard products business
   $ 216.2 91.3 % $ 219.7 91.8 % $ (3.5 )
Net sales – transitional Fab 3 foundry services
   20.7 8.7 19.6 8.2 1.1


Total revenues
   236.9 100.0 239.3 100.0 (2.4 )
Cost of sales

Cost of sales – standard products business
   149.7 63.2 158.4 66.2 (8.8 )
Cost of sales – transitional Fab 3 foundry services
   18.9 8.0 19.6 8.2 (0.7 )


Total cost of sales
   168.5 71.1 178.0 74.4 (9.5 )


Gross profit
   68.4 28.9 61.3 25.6 7.1
Selling, general and administrative expenses
   26.6 11.2 24.5 10.2 2.1
Research and development expenses
   26.7 11.3 21.6 9.0 5.1
Other charges
   15.4 6.5 0.6 0.2 14.9


Operating income (loss)
   (0.5 ) (0.2 ) 14.6 6.1 (15.1 )
Interest expense
   (1.1 ) (0.5 ) (11.0 ) (4.6 ) 9.9
Foreign currency loss, net
   (4.4 ) (1.9 ) (22.5 ) (9.4 ) 18.1
Others, net
   1.2 0.5 1.6 0.7 (0.4 )


   (4.3 ) (1.8 ) (31.9 ) (13.3 ) 27.6


Loss from continuing operations before income tax expense
   (4.8 ) (2.0 ) (17.3 ) (7.2 ) 12.5
Income tax expense
   2.9 1.2 2.0 0.8 0.9


Loss from continuing operations
   (7.7 ) (3.2 ) (19.3 ) (8.1 ) 11.6
Income from discontinued operations, net of tax
   —   —   24.7 10.3 (24.7 )


Net income (loss)
   $ (7.7 ) (3.2 ) $ 5.4 2.3 $ (13.1 )

44

~~Table of Contents~~

~~The following sets forth information relating to our continuing operations:~~

Six Months Ended
June 30, 2021

Six Months Ended
June 30, 2020


Amount

% of
Total revenues

Amount

% of
Total revenues

Change
Amount


(In millions)

Revenues

Net sales – standard products business

Display Solutions
   $ 105.5    44.5 % $ 146.8    61.3 % $ (41.3 )
Power Solutions
   110.7    46.7 72.9    30.5 37.8






Total standard products business
   216.2    91.3 219.7    91.8 (3.5 )
Net sales – transitional Fab 3 foundry services
   20.7    8.7 19.6    8.2 1.1






Total revenues
   $ 236.9    100.0 % $ 239.3    100.0 % $ (2.4 )

Six Months Ended
June 30, 2021

Six Months Ended
June 30, 2020


Amount

% of
    Net sales

Amount

% of
    Net sales

Change
Amount


(In millions)

Gross Profit

Gross profit – standard products business
   $ 66.5    30.8 % $ 61.3    27.9 % $ 5.3
Gross profit – transitional Fab 3 foundry services
   1.8    8.9 —      —   1.8






Total gross profit
   $ 68.4    28.9 % $ 61.3    25.6 % $ 7.1

~~Revenues~~

Total revenues were $236.9 million for the six months ended June 30, 2021, a $2.4 million, or 1.0%, decrease compared to $239.3 million for the six months ended June 30, 2020. This decrease was primarily due to a decrease in revenue related to our standard products business as described below.

~~The standard products business.~~

Net sales from our standard products business were $216.2 million for the six months ended June 30, 2021, a $3.5 million, or 1.6%, decrease compared to $219.7 million for the six months ended June 30, 2020. This decrease was primarily attributable to a decrease in revenue from our mobile OLED display driver ICs stemming from a continuing global shortage in manufacturing capacity, as we outsource manufacturing of these products to external

~~12-inch~~

~~foundries, and a strategic reduction of our lower margin~~

~~non-auto~~

~~LCD business. This decrease was offset in part by a higher demand for power products such as MOSFETs, including~~

~~high-end~~

~~MOSFETs, primarily for TVs and~~

~~e-bikes,~~

~~whereas the revenue for power products in the first half of 2020 was impacted by~~

~~COVID-19-related~~

~~supply chain issues and market softness in China.~~

~~The transitional Fab 3 foundry services.~~

~~Net sales from the transitional Fab 3 foundry services were $20.7 million and $19.6 million for the six months ended June 30, 2021 and 2020, respectively.~~

~~Gross Profit~~

Total gross profit was $68.4 million for the six months ended June 30, 2021 compared to $61.3 million for the six months ended June 30, 2020, a $7.1 million, or 11.6%, increase. Gross profit as a percentage of net sales for the six months ended June 30, 2021 increased to 28.9% compared to 25.6% for the six months ended June 30, 2020. The increase in gross profit and gross profit as a percentage of net sales was primarily due to our standard products business as further described below.

~~The standard products business.~~

Gross profit from our standard products business was $66.5 million for the six months ended June 30, 2021, which represented a $5.3 million, or 8.6%, increase from gross profit of $61.3 million for the six months ended June 30, 2020. Gross profit as a percentage of net sales for the six months ended June 30, 2021 increased to 30.8% compared to 27.9% for the six months ended June 30, 2020. The increase in both gross profit and gross profit margin was primarily attributable to an improved product mix and a higher utilization rate of our internal fabrication facility in Gumi.

45

~~Table of Contents~~

~~Net Sales – Standard Products Business by Geographic Region~~

We report net sales – standard products business by geographic region based on the location to which the products are billed. The following table sets forth our net sales—standard products business by geographic region and the percentage of total net sales—standard products business represented by each geographic region for the six months ended June 30, 2021 and 2020:

Six Months Ended
June 30, 2021

Six Months Ended
June 30, 2020


Amount

% of
Net sales –
standard
products
business

Amount

% of
Net sales –
standard
products
business

Change
Amount


(In millions)

Korea
   $ 57.3    26.5 % $ 52.8    24.0 % $ 4.5
Asia Pacific (other than Korea)
   153.1    70.8 161.8    73.6 (8.7 )
United States
   2.6    1.2 2.2    1.0 0.5
Europe
   2.4    1.1 1.8    0.8 0.6
Others
   0.7    0.3 1.2    0.5 (0.5 )






   $ 216.2    100.0 % $ 219.7    100.0 % $ (3.5 )

Net sales – standard products business in Korea for the six months ended June 30, 2021 increased from $52.8 million to $57.3 million compared to the six months ended June 30, 2020, or by $4.5 million, or 8.6%, primarily due to a higher demand for power products such as MOSFETs, including

~~high-end~~

MOSFETs, primarily for TV and smartphone applications. This increase was offset in part by a decrease in revenue related to our mobile OLED display driver ICs stemming from a continuing global shortage in manufacturing capacity, as we outsource manufacturing of these products to external

~~12-inch~~

~~foundries, and a strategic reduction of our lower margin~~

~~non-auto~~

~~LCD business.~~

Net sales – standard products business in Asia Pacific (other than Korea) for the six months ended June 30, 2021 decreased to $153.1 million from $161.8 million in the six months ended June 30, 2020, or by $8.7 million, or 5.4%, primarily due to a decrease in revenue from our mobile OLED display driver ICs stemming from a continuing global shortage in manufacturing capacity, as we outsource manufacturing of these products to external

~~12-inch~~

~~foundries, which was offset in part by a higher demand for power products such as MOSFETs, including~~

~~high-end~~

~~MOSFETs, primarily for TVs and~~

~~e-bikes.~~

~~Operating Expenses~~

~~Selling,~~

~~General~~

~~and~~

~~Administrative~~

~~Expenses.~~

Selling, general and administrative expenses were $26.6 million, or 11.2% of total revenues, for the six months ended June 30, 2021, compared to $24.5 million, or 10.2% of total revenues, for the six months ended June 30, 2020. The increase of $2.1 million, or 8.7%, was primarily attributable to certain

~~non-income-based~~

tax assessments of $0.6 million as a result of a regular tax examination completed for our primary operating entity in Korea for multiple tax years, and the grant timing of equity-based compensation. This increase was offset in part by a decrease in professional fees mainly comprised of legal and consulting fees.

~~Research~~

~~and~~

~~Development~~

~~Expenses.~~

Research and development expenses were $26.7 million, or 11.3% of total revenues, for the six months ended June 30, 2021, compared to $21.6 million, or 9.0% of total revenues, for the six months ended June 30, 2020. The increase of $5.1 million, or 23.7%, was primarily attributable to an increase in outside service fees and variable overhead expenses, and an increase in material costs for new product development.

~~Other Charges.~~

~~Other charges were $15.4 million for the six months ended June 30, 2021, which were consisted of~~

~~non-recurring~~

~~professional service fees and expenses incurred in connection with the Merger and regulatory requests. Other charges were $0.6 million for the six months ended June 30, 2021, which pertained to~~

~~non-recurring~~

~~professional service fees and expenses incurred in connection with certain treasury and finance initiatives.~~

~~Operating Income (Loss)~~

As a result of the foregoing, operating loss was $0.5 million for the six months ended June 30, 2021 compared to operating income of $14.6 million the six months ended June 30, 2020. As discussed above, the decrease in operating income of $15.1 million resulted primarily from a $14.9 million increase in other charges, a $5.1 million increase in research and development expenses, and a $2.1 million increase in selling, general and administrative expenses. This increase was offset in part by a $7.1 million increase in gross profit.

46

~~Table of Contents~~

~~Other Income (Expense)~~

~~Interest~~

~~Expense.~~

Interest expenses was $1.1 million and $11.0 million for the six months ended June 30, 2021 and June 30, 2020, respectively. Interest expenses was incurred primarily under our 2021 Notes and Exchangeable Notes. We redeemed all outstanding 2021 Notes on October 2, 2020. Our Exchangeable Notes were exchanged for common stock prior to their maturity date of March 1, 2021. From and after October 2, 2020 and March 1, 2021, we have not incurred interest expense associated with the 2021 Notes and Exchangeable Notes, respectively.

Foreign

Currency

Loss,

Net.

Net foreign currency loss for the ~~six~~three months ended ~~June 30, 2021~~March 31, 2022 was ~~$4.4~~$0.7 million compared to net foreign currency loss of ~~$22.5~~$4.7 million for the ~~six~~three months ended ~~June 30, 2020.~~March 31, 2021. The net foreign currency loss for the ~~six~~three months ended ~~June 30,~~March 31, 2022 and March 31, 2021 ~~and June 30, 2020~~ was due to the depreciation in value of the Korean won relative to the U.S. dollar during the period.

A substantial portion of our net foreign currency gain or loss is

non-cash

translation gain or loss associated with intercompany long-term loans to our Korean subsidiary, which are denominated in U.S. dollars, and are affected by changes in the exchange rate between the Korean won and the U.S. dollar. As of ~~June 30,~~March 31, 2022 and March 31, 2021, ~~and June 30, 2020,~~ the outstanding intercompany loan balances, including accrued interest between our Korean subsidiary and our Dutch subsidiary, were ~~$387~~$348 million and ~~$691~~$382 million, respectively. Foreign currency translation gain or loss from intercompany balances were included in determining our consolidated net income (loss) since the intercompany balances were not considered long-term investments in nature because management intended to settle these intercompany balances at their respective maturity dates.

Others,

Net.

Others were comprised of ~~rental~~interest income, ~~interest~~rental income, and gains and losses from valuation of derivatives which were designated as hedging instruments. Others for the ~~six~~three months ended ~~June 30,~~March 31, 2022 and March 31, 2021 ~~and June 30, 2020~~ was ~~$1.2~~$0.9 million and ~~$1.6~~$0.6 million, respectively.

Income Tax Expense

Income tax expense was ~~$2.9~~$3.5 million for the ~~six~~three months ended ~~June 30,~~March 31, 2022, which was primarily attributable to the estimated taxable income in our Korean subsidiary for the respective period. Income tax expense was $0.3 million for the three months ended March 31, 2021, which was primarily attributable to interest on intercompany loan balances, and certain income-based tax assessments of $0.6 million as a result of a regular tax examination completed during the second quarter of 2021 for our Korean subsidiary for multiple tax years. Income tax expense was $2.0 million for the six months ended June 30, 2020, which was primarily attributable to interest on intercompany loan balances and the estimated taxable income for our Korean subsidiary, combined with its ability to utilize net operating loss carryforwards up to 60%.

~~Loss from Continuing Operations~~

Loss from continuing operations for the six months ended June 30, 2021 was $7.7 million compared to loss from continuing operations of $19.3 million for the six months ended June 30, 2020. The $11.6 million improvement in results from continuing operations was primarily attributable to an $18.1 million improvement in net foreign currency loss and a $9.9 million decrease in interest expense, which were offset in part by ~~a $15.1 million decrease in operating income.~~

~~Income from Discontinued Operations, Net of Tax~~

~~On March 30, 2020, we entered into~~ the ~~Business Transfer Agreement~~tax benefit recognized on the loss for the ~~sale~~first quarter of our Foundry Services Group business and Fab 4. As a result, the results of the Foundry Services Group business were classified as discontinued operations in our consolidated statements of operations and excluded2021 from our continuing operations for all periods presented. Income from discontinued operations, net of tax was $24.7 million for the six months ended June 30, 2020. On September 1, 2020, we completed the sale of our Foundry Services Group business and Fab 4 for a purchase price equal to approximately $350.6 million in cash. We have not incurred a gain or loss from discontinued operations in 2021 as the sale of the Foundry Service Group business and Fab 4 was completed in 2020.Korean subsidiary.

Net Income (Loss)

As a result of the foregoing, a net ~~loss~~income of ~~$7.7~~$9.5 million was recorded for the ~~six~~three months ended ~~June 30, 2021~~March 31, 2022 compared to a net ~~income~~loss of ~~$5.4~~$7.5 million for the ~~six~~three months ended ~~June 30, 2020.~~March 31, 2021. As discussed above, the ~~decrease~~$17.0 million increase in net income ~~of $13.1~~was primarily attributable to a $15.0 million ~~primarily resulted from~~increase in operating income, a ~~$24.7~~$4.0 million improvement in net foreign currency loss and a $0.9 million decrease in ~~income from discontinued operations, net of tax,~~interest expense, which was offset in part by ~~an $11.6~~a $3.2 million ~~improvement~~increase in ~~loss from continuing operations.~~income tax expense.

4741

Table of Contents

Liquidity and Capital Resources

Our principal capital requirements are to fund sales and marketing, invest in research and development and capital equipment, and to fund working capital needs. We calculate working capital as current assets less current liabilities.

Our principal sources of liquidity are our cash, cash equivalents, cash flows from operations and financing activities. Our ability to manage cash and cash equivalents may be limited, as our primary cash flows are dictated ~~from time to time~~ by the terms of our sales and supply agreements, contractual obligations, debt instruments and legal and regulatory requirements. From time to time, we may sell accounts receivable to third parties under factoring agreements or engage in accounts receivable discounting to facilitate the collection of cash. In addition, from time to time, we may make payments to our vendors on extended terms with their consent. As of ~~June 30, 2021,~~March 31, 2022, we dodid not have any accounts payable on extended terms or payment deferment with our vendors.

As of June 29, 2018, our Korean subsidiary entered into an arrangement whereby it (i) acquired a water treatment facility from SK hynix for $4.2 million to support our fabrication facility in Gumi, Korea, and (ii) subsequently sold the water treatment facility for $4.2 million to a third party management company that we engaged to run the facility for a

~~On September~~10-year

term beginning July 1, ~~2020, we completed~~2018. As of March 31, 2022, the ~~sale~~outstanding obligation of this arrangement is approximately $22.5 million for remaining service term through 2028.

As of March 31, 2022, cash and cash equivalents held by our Korean subsidiary were $279.4 million, which represents 98% of our ~~Foundry Services Group business~~total cash and ~~Fab 4 to Key Foundry Co., Ltd. in exchange for~~cash equivalents on a purchase price equal to approximately $350.6 million in cash. The purchase price was paid in a combination of U.S. Dollars in the amount of $46.5 million and Korean Won in the amount of approximately KRW 360.6 billion.

On October 2, 2020, we redeemed of all of our outstanding 2021 Notes. We paid approximately $227.4 million to fully redeem all of the outstanding $224.25 million aggregate principal amount of the 2021 Notes at a redemption price equal to the sum of 100% of the principal amount plus accrued and unpaid interest thereon.

On January 17, 2017, we issued an aggregate of $86.3 million in principal amount of our Exchangeable Notes. Prior to the March 1, 2021 maturity of our Exchangeable Notes, holders elected to exchange for an aggregate of 10,144,131 shares of our common stock in satisfaction in full of the remaining outstanding obligations under the Exchangeable Notes.

consolidated basis. We currently believe that we will have sufficient cash reserves from cash on hand and expected cash from operations to fund our operations as well as capital expenditures for the next 12 months and the foreseeable future.

Working Capital

Our working capital balance as of ~~June 30, 2021~~March 31, 2022 was ~~$312.9~~$337.2 million compared to ~~$236.0~~$323.6 million as of December 31, ~~2020.~~2021. The ~~$76.9~~$13.6 million increase was primarily attributable to ~~the exchange of~~a $5.4 million increase in cash and cash equivalents and a $6.6 million increase in advance payments to certain suppliers, including external foundries to meet our ~~Exchangeable Notes for common stock prior to their maturity date of March 1, 2021.~~

~~Cash Flows~~

The consolidated statements of cash flows have not been adjusted to separately disclose cash flows related to discontinued operations for the six months ended June 30, 2020, but the material items in the operating and investing activities of cash flows relating to discontinued operations in the referred period are disclosed in “Item 1. Financial Statements and Supplementary Data – Notes to Consolidated Financial Statements – Note 3 – Discontinued Operations” included elsewhere in this Report.planned production.

Cash Flows from Operating Activities

Cash inflow provided by operating activities totaled ~~$10.4~~$12.8 million for the ~~six~~three months ended ~~June 30, 2021,~~March 31, 2022, compared to ~~$57.1~~$21.2 million of cash inflow provided by operating activities for the ~~six~~three months ended ~~June 30, 2020.~~March 31, 2021. The net operating cash inflow for the ~~six~~three months ended ~~June 30, 2021~~March 31, 2022 reflects our net ~~loss~~income of ~~$7.7~~$9.5 million, as adjusted favorably by ~~$35.1~~$13.9 million, which mainly consisted of depreciation and amortization, provision for severance benefits, ~~restructuring and other charges, stock-based compensation~~ and net foreign currency loss, and net unfavorable impact of ~~$17.0~~$10.6 million from changes of operating assets and liabilities.

Cash Flows from Investing Activities

Cash outflow used in investing activities totaled ~~$9.6~~$2.1 million for the ~~six~~three months ended ~~June 30, 2021,~~March 31, 2022, compared to ~~$11.8~~$1.4 million of cash outflow used in investing activities for the ~~six~~three months ended ~~June 30, 2020.~~March 31, 2021. The ~~$2.3~~$0.8 million ~~decrease~~increase was primarily attributable to a ~~$4.0~~$1.1 million net increase in hedge collateral, which was offset in part by a $0.1 million decrease in purchase of property, plant and ~~equipment and a $2.4 million net decrease in hedge collateral, which were offset in part by a $4.1 million net increase in guarantee deposits.~~equipment.

48

~~Table of Contents~~

Cash Flows from Financing Activities

Cash inflow provided by financing activities totaled ~~$0.6~~$0.8 million for the ~~six~~three months ended ~~June 30, 2021,~~March 31, 2022, compared to ~~$0.7~~$0.8 million of cash ~~outflow used in~~inflow provided by financing activities for the ~~six~~three months ended ~~June 30, 2020.~~March 31, 2021. The financing cash inflow for the ~~six~~three months ended ~~June 30,~~March 31, 2022 was primarily attributable to $1.8 million of proceeds received from the issuance of common stock in connection with the exercise of stock options, which was offset in part by a payment of $0.8 million for the repurchase of our common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. The financing cash inflow for the three months ended March 31, 2021 was primarily attributable to $2.5 million of proceeds received from the issuance of common stock in connection with the exercise of stock options, which was offset in part by a payment of ~~$1.7~~$1.5 million for the repurchase of our common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. The financing cash outflow for the six months ended June 30, 2020 was primarily attributable to a payment of $1.0 million for the repurchase of our common stock to satisfy tax withholding obligation in connection with the vesting of restricted stock units, which was offset in part by a $0.7 million of proceeds received from the issuance of common stock in connection with the exercise of stock options.

Capital Expenditures

We routinely make capital expenditures for fabrication facility maintenance, enhancement of our existing ~~facilities~~facility and reinforcement of our global research and development capability. For the ~~six~~three months ended ~~June 30, 2021,~~March 31, 2022, capital expenditures for property, plant and equipment were ~~$4.9~~$0.9 million, a ~~$4.0~~$0.1 million, or ~~45.0%~~12.8%, decrease from ~~$8.8~~$1.1 million ~~including a $4.4 million capital expenditures for discontinued operations,~~ for the ~~six~~three months ended ~~June 30, 2020.~~March 31, 2021. The capital expenditures for the ~~six~~three months ended ~~June 30,~~March 31, 2022 and 2021 ~~and 2020~~ were related to meeting our customer demand and supporting technology and facility improvement at our fabrication ~~facilities.~~facility.

4942

Table of Contents

~~Contractual Obligations~~

~~The following summarizes our contractual obligations as of June 30, 2021:~~

Payments Due by Period


Total

Remainder
of
2021

2022

2023

2024

2025

Thereafter


(In millions)

Operating leases(1)
   $ 4.8    $ 1.4    $ 1.6    $ 0.8    $ 0.6    $ 0.4    $ —
Finance leases(1)
   0.2    0.0    0.1    0.1    —      —      —
Water Treatment Services(1)(2)
   27.2    2.1    4.1    4.0    3.9    3.8    9.3
Others(3)
   9.1    1.9    4.1    3.0    0.1    0.1    —

~~(1)~~

~~Assumes constant currency exchange rate for Korean won to U.S. dollars of 1,130:1, the exchange rate as of June 30, 2021.~~

~~(2)~~

~~Includes future payments for water treatment services for our fabrication facility in Gumi, Korea based on the contractual terms.~~

~~(3)~~

~~Includes license agreements and other contractual obligations.~~

~~We lease land, office space and equipment under various operating lease agreements that expire through 2025.~~

~~We are a party to an arrangement for the water treatment facility in Gumi, Korea, which includes a~~

~~10-year~~

~~service agreement beginning July 1, 2018.~~

Beginning in July 2018, we have contributed a certain percentage of severance benefits, accrued for eligible employees for their services beginning January 1, 2018, to certain severance insurance deposit accounts. These accounts consist of time deposits and other guaranteed principal and interest, and are maintained at insurance companies, banks or security companies for the benefit of employees. We deduct the contributions made to these severance insurance deposit accounts from our accrued severance benefits. As of June 30, 2021, our accrued severance benefits, net, totaled $39.5 million and cumulative contributions to these severance insurance deposit accounts amounted to $13.3 million.

We follow U.S. GAAP guidance on uncertain tax positions. Our unrecognized tax benefits totaled $0.4 million as of June 30, 2021. These unrecognized tax benefits have been excluded from the above table because we cannot estimate the period of cash settlement with the respective taxing authorities.

~~Off-Balance~~

~~Sheet Arrangements~~

~~As of June 30, 2021, we did not have any~~

~~off-balance~~

~~sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation~~

~~S-K.~~

50

~~Table of Contents~~

Critical Accounting Policies and Estimates

Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities as of the date of the financial statements, the reported amounts of revenues and expenses during the reporting periods and the related disclosures in our consolidated financial statements and accompanying notes.

We believe that our significant accounting policies, which are described further in Note 1 to our consolidated financial statements in our Annual Report on Form

10-K

for our fiscal year ended December 31, ~~2020,~~2021, or our ~~2020~~2021 Form

10-K,

are critical due to the fact that they involve a high degree of judgment and estimates about the effects of matters that are inherently uncertain. We base these estimates and judgments on historical experience, knowledge of current conditions and other assumptions and information that we believe to be reasonable. Estimates and assumptions about future events and their effects cannot be determined with certainty. Accordingly, these estimates may change as new events occur, as more experience is acquired, as additional information is obtained and as the business environment in which we operate changes.

A description of our critical accounting policies that involve significant management judgement appears in our ~~2020~~2021 Form

10-K,

under “Management’s Discussion and Analysis of Financial Conditions and Reports of Operations—Critical Accounting Policies and Estimates.” There have been no other material changes to our critical accounting policies and estimates as compared to our critical accounting policies and estimates included in our ~~2020~~2021 Form

10-K.

Recent

Accounting

Pronouncements

For a full description of new accounting pronouncements and recently adopted accounting pronouncements, please see “Item 1. Interim Consolidated Financial Statements—Notes to Consolidated Financial Statements—Note 1. Business, Basis of Presentation and Significant Accounting Policies” in this Report.

5143

Table of Contents

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

We are exposed to the market risk that the value of a financial instrument will fluctuate due to changes in market conditions, primarily from changes in foreign currency exchange rates. In the normal course of our business, we are subject to market risks associated with currency movements on our assets and liabilities.

Foreign Currency Exposures

We have exposure to foreign currency exchange rate fluctuations on net income from our subsidiaries denominated in currencies other than U.S. dollars, as our foreign subsidiaries in Korea, Taiwan, China, Japan and Hong Kong use local currency as their functional currency. From time to time these subsidiaries have cash and financial instruments in local currency. The amounts held in Japan, Taiwan, Hong Kong and China are not material in regards to foreign currency movements. However, based on the cash and financial instruments balance at ~~June 30, 2021~~March 31, 2022 for our Korean subsidiary, a 10% devaluation of the Korean won against the U.S. dollar would have resulted in a decrease of ~~$2.2~~$3.1 million in our U.S. dollar financial instruments and cash balances.

See “Note 9.7. Derivative Financial Instruments” to our consolidated financial statements under “Item 1. Interim Consolidated Financial Statements” and “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations—Factors Affecting Our Results of Operations—Impact of Foreign Currency Exchange Rates on Reported Results of Operations” for additional information regarding our foreign exchange hedging activities.

5244

Table of Contents

Item 4.

Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic reports filed or submitted under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

In connection with the preparation of this Report, we carried out an evaluation under the supervision of and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, as of ~~June 30, 2021,~~March 31, 2022, of the effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined in Rules

13a-15(e)

and

15d-15(e)

under the Exchange Act. Based upon this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of ~~June 30, 2021.~~March 31, 2022.

Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended ~~June 30, 2021~~March 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

5345

Table of Contents

PART II. OTHER INFORMATION

Item 1.

Legal Proceedings

For a discussion of legal proceedings, see ~~“Item 1. Interim Consolidated Financial Statements—Notes to Consolidated Financial Statements—Note 19. Commitments and Contingencies” in this Report and~~ “Part I: Item 3. Legal Proceedings” of our ~~2020~~2021

Form 10-K.

See also “Item 1A. Risk Factors” in this Report and “Part I: Item 1A. Risk Factors” of our ~~2020~~2021

Form 10-K

for additional information.

Item 1A.

Risk Factors

The Company is subject to risks and uncertainties, any of which could have a significant or material adverse effect on our business, financial condition, liquidity or consolidated financial statements. You should carefully consider the risk factors disclosed in Part I, Item 1A of our ~~2020~~2021 Form

10-K

(including that the impact of the

COVID-19

pandemic, such as the ongoing lockdowns in Shanghai, China, may also exacerbate the risks discussed therein), herein and other reports we have filed with the SEC. In addition, the recent geopolitical conflict between Russia and Ukraine, and any sanctions, export controls or other retaliatory actions against, or restrictions on doing business with Russia, as well as any disruption, instability or volatility in the global markets, industries and supply chains resulting from such conflict, could adversely affect our business, even though at present we are not experiencing or expecting any notable negative effect on our financial condition or results of operations. The risks described herein and therein are not the only ones we face. This information should be considered carefully together with the other information contained in this Report and the other reports and materials the Company files with the SEC.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

~~Risks Related to~~The following table shows the ~~Merger~~

~~There are risks and uncertainties associated with the Merger.~~

On March 25, 2021, we entered into the Merger Agreement with Parent and Merger Sub, pursuant to which, among other things, and subject to the terms and conditions thereof, Merger Sub will be merged with and into the Company, with the Company continuing its corporate existence as the surviving corporation in the Merger and becoming a wholly owned subsidiary of Parent. The consummation of the Merger is conditioned on the receipt of the approval of our stockholders, as well as the satisfaction of other customary closing conditions, including (i) the receipt of certain required or requested governmental approvals or authorizations (including from CFIUS and MOTIE), (ii) the absence of any order or law issued, enacted or deemed applicable by certain governmental authorities specified in the Merger Agreement that makes consummation of the Merger illegal and that remains in effect, (iii) the absence of a Company Material Adverse Effect (as defined in the Merger Agreement) and (iv) other customary closing conditions, including the accuracy of each party’s representations and warranties, and each party’s compliance with its obligations under the Merger Agreement (subject in the case of this clause (iv) to certain materiality qualifiers). There is no assurance that the conditions to the Merger will be satisfied in a timely manner or at all. Additionally, if the Merger is not completed, we may suffer a number of consequences that could adversely affect our business, results of operations, and stock price. There are numerous other risksmonthly activity related to ~~the Merger as well, including the following:~~

~~the possibility that any or all~~our repurchases of ~~the conditions precedent to the consummation of the proposed Merger, including the receipt of stockholder and regulatory approvals or authorizations, may not be satisfied or waived;~~

~~unanticipated difficulties or expenditures relating to the proposed Merger;~~

~~the failure to consummate the proposed Merger may result in negative publicity and a negative impression of us in the investment community;~~

54

~~Table of Contents~~

required or requested regulatory approvals or authorizations from governmental entities may delay the proposed Merger or result in the imposition of conditions that could cause Parent to abandon the Merger;

~~the occurrence of any event, change or circumstance that could give rise to the termination of the Merger Agreement;~~

~~the effects that any termination of the Merger Agreement may have on the Company or our business, including the risks that (a) the price of our~~ common stock may decline significantly if the Merger is not completed, (b) the Merger Agreement may be terminated in circumstances requiring the Company to pay Parent a termination fee, or (c) the circumstances of the termination, including the possible imposition of a

~~12-month~~

~~tail period during which the termination fee could be payable upon certain subsequent transactions, may have a chilling effect on alternatives to the Merger;~~

~~the diversion of and attention of management of Magnachip on transaction-related issues;~~

legal proceedings, judgments or settlements, including those that have been and may in the future be instituted against Magnachip, our Board of Directors and executive officers and others following the announcement of the proposed Merger;

~~disruptions of current plans and operations caused by the announcement and pendency of the proposed Merger;~~

~~potential difficulties in employee retention (including executive and other key officers) due to the announcement and pendency of the proposed Merger;~~

~~the response of customers, suppliers, business partners and regulators to the announcement of the proposed Merger;~~

~~the effect of limitations that the Merger Agreement places on our ability to operate our business or engage in alternative transactions;~~

~~the Merger may be completed even though certain events occur prior to consummation of the Merger that materially and adversely affect us; and~~

other risks and uncertainties and the factors identified under “Forward-Looking Information” in our Proxy Statement on Schedule 14A filed on May 7, 2021 and under “Risk Factors” in Part I, Item 1A of Magnachip’s Annual Report on

~~Form 10-K~~

for the ~~year~~quarter ended ~~December~~March 31, ~~2020, and updated in subsequent reports filed by Magnachip with the SEC.~~2022.

In addition, we have incurred, and will continue to incur, significant costs, expenses and fees for professional services and other transaction costs in connection with the Merger, and these fees and costs are payable by us regardless of whether the Merger is consummated.

Lawsuits have been filed, and other lawsuits may be filed, against the Company and current or former members of our Board of Directors in connection with the Merger, and an adverse ruling in any such lawsuit may delay or prevent the completion of the Merger or result in an award of damages against the Company.

See “Item 1. Interim Consolidated Financial Statements—Notes to Consolidated Financial Statements—19. Commitments and Contingencies” in this Report for a description of the Merger-related lawsuits.

Additional lawsuits arising out of or relating to the Merger Agreement or the Merger may be filed in the future. The results of complex legal proceedings are difficult to predict and could delay or prevent the completion of the Merger. The existence of litigation relating to the Merger could impact the likelihood of obtaining stockholder approval of the Merger. Moreover, the pending litigation is, and any future additional litigation could be, time consuming and expensive and could divert management’s attention away from its regular business.


Period	Total Number of Shares Purchased		Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs(1)		Approximate dollar value of Shares that may yet be Purchased under the Plans or Programs (in thousands)(1)
January 2022		—		—		—		—
February 2022		—		—		—		—
March 2022		1,031,576	$	16.69		1,031,576	$	37,500

Total		1,031,576					$	37,500

(1)

On December 21, 2021, the Company’s Board of Directors authorized the Company to repurchase up to $75 million of the Company’s common stock. As an immediate step towards implementing the approved stock repurchase program, the Company entered into an ASR Agreement on December 21, 2021 with JPM to repurchase an aggregate of $37.5 million of the Company’s common stock. Pursuant to the terms of the ASR Agreement dated December 21, 2021, we paid to JPM $37.5 million in cash and received an initial delivery of 994,695 shares of our common stock in the open market. In March 2022, the previously announced repurchase of $37.5 million of our common stock was completed pursuant to the ASR Agreement, and as a result, we additionally received 1,031,576 shares of our common stock.

55

46

Table of Contents

Item 6.

Exhibits.


Exhibit Number		Description

~~2.1~~		Letter Agreement, dated as of June 11, 2021, by and among Magnachip Semiconductor Corporation, South Dearborn Limited and Michigan Merger Sub, Inc. (incorporated by reference to Exhibit 2.1 to our Current Report on Form ~~8-K~~ ~~filed on June 14, 2021).~~

31.1 #		Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 of the Chief Executive Officer.

31.2 #		Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 of the ~~Principal~~Chief Financial Officer.

32.1†		Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of the Chief Executive Officer.

32.2†		Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, of the Chief Financial Officer.

101.INS #		Inline XBRL Instance Document.

101.SCH #		Inline XBRL Taxonomy Extension Schema Document.

101.CAL #		Inline XBRL Taxonomy Extension Calculation Linkbase Document.

101.DEF #		Inline XBRL Taxonomy Extension Definition Linkbase Document.

101.LAB #		Inline XBRL Taxonomy Extension Label Linkbase Document.

101.PRE #		Inline XBRL Taxonomy Extension Presentation Linkbase Document.

104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

Footnotes:

#	Filed herewith

†	Furnished herewith

5647

Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


	MAGNACHIP SEMICONDUCTOR CORPORATION (Registrant)

Dated: ~~August~~May 6, ~~2021~~2022	By:	/s/ Young-Joon Kim
		Young-Joon Kim
		Chief Executive Officer (Principal Executive Officer)

Dated: ~~August~~May 6, ~~2021~~2022	By:	/s/ Shin Young ~~Soo Woo~~Park
		Shin Young ~~Soo Woo~~Park
		Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)

5748


		Page No.
PART I FINANCIAL INFORMATION			3
Item 1.	Interim Consolidated Financial Statements (Unaudited)		3
	Magnachip Semiconductor Corporation and Subsidiaries Consolidated Balance Sheets as of ~~June 30, 2021~~March 31, 2022 and December 31, ~~2020~~2021		3
	Magnachip Semiconductor Corporation and Subsidiaries Consolidated Statements of Operations for the Three ~~and Six~~ Months Ended ~~June 30,~~March 31, 2022 and 2021 ~~and 2020~~		4
	Magnachip Semiconductor Corporation and Subsidiaries Consolidated Statements of Comprehensive Income (Loss) for the Three ~~and Six~~ Months Ended ~~June 30,~~March 31, 2022 and 2021 ~~and 2020~~		5
	Magnachip Semiconductor Corporation and Subsidiaries Consolidated Statements of Changes in Stockholders’ Equity for the Three ~~and Six~~ Months Ended ~~June 30,~~March 31, 2022 and 2021 ~~and 2020~~		6
	Magnachip Semiconductor Corporation and Subsidiaries Consolidated Statements of Cash Flows for the ~~Six~~Three Months Ended ~~June 30,~~March 31, 2022 and 2021 ~~and 2020~~		7
	Magnachip Semiconductor Corporation and Subsidiaries Notes to Consolidated Financial Statements		8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		2826
Item 3.	Quantitative and Qualitative Disclosures About Market Risk		5244
Item 4.	Controls and Procedures		5345
PART II OTHER INFORMATION			5446
Item 1.	Legal Proceedings		5446
Item 1A.	Risk Factors		5446
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds		46
Item 6.	Exhibits		5647
SIGNATURES			5748


	June 30, 2021			December 31, 2020
	(In thousands of U.S. dollars, except share data)
Assets
Current assets
Cash and cash equivalents	$	271,880		$	279,940
Accounts receivable, net		56,730			64,390
Inventories, net		41,369			39,039
Other receivables		9,173			4,338
Prepaid expenses		6,836			7,332
Hedge collateral (Note 9)		4,830			5,250
Other current assets (Notes 10 and 19)		5,117			9,321

Total current assets		395,935			409,610
Property, plant and equipment, net		94,721			96,383
Operating lease right-of-use assets		4,520			4,632
Intangible assets, net		2,541			2,727
Long-term prepaid expenses		5,626			4,058
Deferred income taxes		43,069			44,541
Other non-current assets		11,141			9,739

Total assets	$	557,553		$	571,690

Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable	$	52,040		$	52,164
Other accounts payable		9,119			2,531
Accrued expenses (Note 8)		13,020			16,241
Accrued income taxes		1,679			12,398
Operating lease liabilities		2,181			2,210
Current portion of long-term borrowings, net		—			83,479
Other current liabilities (Note 10)		5,001			4,595

Total current liabilities		83,040			173,618
Accrued severance benefits, net		39,520			40,462
Non-current operating lease liabilities		2,338			2,422
Other non-current liabilities		10,024			9,588

Total liabilities		134,922			226,090

Commitments and contingencies (Note 19)		0			0
Stockholders’ equity
Common stock, $0.01 par value, 150,000,000 shares authorized, 55,562,907 shares issued and 46,350,945 outstanding at June 30, 2021 and 44,943,854 shares issued and 35,783,347 outstanding at December 31, 2020		556			450
Additional paid-in capital		253,244			163,010
Retained earnings		279,163			286,834
Treasury stock, 9,211,962 shares at June 30, 2021 and 9,160,507 shares at December 31, 2020, respectively		(109,407	)		(108,397	)
Accumulated other comprehensive income (loss)		(925	)		3,703

Total stockholders’ equity		422,631			345,600

Total liabilities and stockholders’ equity	$	557,553		$	571,690


	Common Stock				Additional Paid-In Capital			Retained Earnings (Deficit)			Treasury Stock			Accumulated Other Comprehensive Income (Loss)			Total
(In thousands of U.S. dollars, except share data)	Shares		Amount		Additional Paid-In Capital			Retained Earnings (Deficit)			Treasury Stock			Accumulated Other Comprehensive Income (Loss)			Total
Three Months Ended June 30, 2021:
Balance at March 31, 2021		46,257,413	$	555	$	250,829		$	279,361		$	(109,407	)	$	(991	)	$	420,347
Stock-based compensation		—		—		2,405			—			—			—			2,405
Exercise of stock options		1,000		0		11			—			—			—			11
Settlement of restricted stock units		92,532		1		(1	)		—			—			—			—
Other comprehensive income, net		—		—		—			—			—			66			66
Net loss		—		—		—			(198	)		—			—			(198	)

Balance at June 30, 2021		46,350,945	$	556	$	253,244		$	279,163		$	(109,407	)	$	(925	)	$	422,631

Three Months Ended June 30, 2020:
Balance at March 31, 2020		35,054,682	$	442	$	153,286		$	(81,880	)	$	(107,649	)	$	14,645		$	(21,156	)
Stock-based compensation		—		—		1,643			—			—			—			1,643
Exercise of stock options		88,351		1		662			—			—			—			663
Other comprehensive loss, net		—		—		—			—			—			(4,146	)		(4,146	)
Net income		—		—		—			29,171			—			—			29,171

Balance at June 30, 2020		35,143,033	$	443	$	155,591		$	(52,709	)	$	(107,649	)	$	10,499		$	6,175


	Three Months Ended			Six Months Ended			Three Months Ended			Six Months Ended
	June 30, 2021						June 30, 2020
Beginning balance	$	(6,281	)	$	(5,901	)	$	(4,807	)	$	(5,947	)
Change in reserve
Inventory reserve charged to costs of sales		(3,186	)		(5,350	)		(1,794	)		(3,069	)
Sale of previously reserved inventory		1,343			1,977			747			1,653

		(1,843	)		(3,373	)		(1,047	)		(1,416	)
Write off		28			930			642			1,141
Translation adjustments		(5	)		243			(95	)		221
Reclassified to assets held for sale		—			—			—			694

Ending balance	$	(8,101	)	$	(8,101	)	$	(5,307	)	$	(5,307	)


	December 31, 2020
	Gross amount		Accumulated amortization			Net amount
Intellectual property assets	$	9,486	$	(6,759	)	$	2,727

Intangible assets	$	9,486	$	(6,759	)	$	2,727


As of December 31, 2020	Gross amounts of recognized assets/liabilities		Gross amounts offset in the balance sheets		Net amounts of assets/liabilities presented in the balance sheets		Gross amounts not offset in the balance sheets				Net amount
As of December 31, 2020	Gross amounts of recognized assets/liabilities		Gross amounts offset in the balance sheets				Financial instruments		Cash collateral pledged		Net amount
Asset Derivatives:
Zero cost collars	$	2,036	$	0	$	2,036	$	0	$	0	$	2,036
Liability Derivatives:
Zero cost collars	$	195	$	0	$	195	$	0	$	0	$	195


Derivatives in ASC 815 Cash Flow Hedging Relationships	Amount of Income Recognized in AOCI on Derivatives				Location/Amount of Gain (Loss) Reclassified from AOCI Into Statement of Operations							Location/Amount of Gain (Loss) Recognized in Statement of Operations on Derivatives
	Three Months Ended June 30,						Three Months Ended June 30,							Three Months Ended June 30,
	2021		2020				2021		2020					2021			2020
Zero cost collars	$	432	$	2,204		Net sales	$	475	$	(193	)		Other income, net	$	(58	)	$	55

	$	432	$	2,204			$	475	$	(193	)			$	(58	)	$	55


	Carrying Value June 30, 2021		Fair Value Measurement June 30, 2021		Quoted Prices in Active Markets for Identical Liability (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Liabilities:
Derivative liabilities (other current liabilities)	$	846	$	846		—	$	846		—
Derivative liabilities (other non-current liabilities)	$	66	$	66		—	$	66		—


	Carrying Value December 31, 2020		Fair Value Measurement December 31, 2020		Quoted Prices in Active Markets for Identical Asset / Liability (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)
Assets:
Derivative assets (other current assets)	$	2,036	$	2,036		—	$	2,036		—
Liabilities:
Derivative liabilities (other current liabilities)	$	195	$	195		—	$	195		—


	December 31, 2020
	Carrying Value		Fair Value
		(In thousands of U.S. dollars )
Borrowings:
5.0% Exchangeable Senior Notes due March 2021 (Level 2)	$	83,479	$	145,466


	December 31,
	2020
5.0% Exchangeable Senior Notes due March 2021	$	83,740
Less: unamortized discount and debt issuance costs		(261	)

Total borrowings, net		83,479
Less: current portion of long-term borrowings, net		83,479

Long-term borrowings, net	$	0


Three Months Ended June 30, 2021	Foreign currency translation adjustments		Derivative adjustments			Total
Beginning balance	$	11	$	(1,002	)	$	(991	)

Other comprehensive income before reclassifications		109		432			541
Amounts reclassified from accumulated other comprehensive income		—		(475	)		(475	)

Net current-period other comprehensive income (loss)		109		(43	)		66

Ending balance	$	120	$	(1,045	)	$	(925	)


Three Months Ended June 30, 2020	Foreign currency translation adjustments			Derivative adjustments			Total
Beginning balance	$	18,046		$	(3,401	)	$	14,645

Other comprehensive income (loss) before reclassifications		(6,543	)		2,204			(4,339	)
Amounts reclassified from accumulated other comprehensive loss		—			193			193

Net current-period other comprehensive income (loss)		(6,543	)		2,397			(4,146	)

Ending balance	$	11,503		$	(1,004	)	$	10,499


Six Months Ended June 30, 2021	Foreign currency translation adjustments			Derivative adjustments			Total
Beginning balance	$	2,069		$	1,634		$	3,703

Other comprehensive loss before reclassifications		(1,949	)		(1,693	)		(3,642	)
Amounts reclassified from accumulated other comprehensive income		—			(986	)		(986	)

Net current-period other comprehensive loss		(1,949	)		(2,679	)		(4,628	)

Ending balance	$	120		$	(1,045	)	$	(925	)


Six Months Ended June 30, 2020	Foreign currency translation adjustments			Derivative adjustments			Total
Beginning balance	$	(4,205	)	$	1,545		$	(2,660	)

Other comprehensive income (loss) before reclassifications		15,708			(2,800	)		12,908
Amounts reclassified from accumulated other comprehensive loss		—			251			251

Net current-period other comprehensive income (loss)		15,708			(2,549	)		13,159

Ending balance	$	11,503		$	(1,004	)	$	10,499


	Six Months Ended June 30, 2021						Six Months Ended June 30, 2020
	Amount			% of Total revenues			Amount			% of Total revenues			Change Amount
	(In millions)
Revenues
Net sales – standard products business	$	216.2			91.3	%	$	219.7			91.8	%	$	(3.5	)
Net sales – transitional Fab 3 foundry services		20.7			8.7			19.6			8.2			1.1

Total revenues		236.9			100.0			239.3			100.0			(2.4	)
Cost of sales
Cost of sales – standard products business		149.7			63.2			158.4			66.2			(8.8	)
Cost of sales – transitional Fab 3 foundry services		18.9			8.0			19.6			8.2			(0.7	)

Total cost of sales		168.5			71.1			178.0			74.4			(9.5	)

Gross profit		68.4			28.9			61.3			25.6			7.1
Selling, general and administrative expenses		26.6			11.2			24.5			10.2			2.1
Research and development expenses		26.7			11.3			21.6			9.0			5.1
Other charges		15.4			6.5			0.6			0.2			14.9

Operating income (loss)		(0.5	)		(0.2	)		14.6			6.1			(15.1	)
Interest expense		(1.1	)		(0.5	)		(11.0	)		(4.6	)		9.9
Foreign currency loss, net		(4.4	)		(1.9	)		(22.5	)		(9.4	)		18.1
Others, net		1.2			0.5			1.6			0.7			(0.4	)

		(4.3	)		(1.8	)		(31.9	)		(13.3	)		27.6

Loss from continuing operations before income tax expense		(4.8	)		(2.0	)		(17.3	)		(7.2	)		12.5
Income tax expense		2.9			1.2			2.0			0.8			0.9

Loss from continuing operations		(7.7	)		(3.2	)		(19.3	)		(8.1	)		11.6
Income from discontinued operations, net of tax		—			—			24.7			10.3			(24.7	)

Net income (loss)	$	(7.7	)		(3.2	)	$	5.4			2.3		$	(13.1	)


	Payments Due by Period
	Total		Remainder of 2021		2022		2023		2024		2025		Thereafter
	(In millions)
Operating leases(1)	$	4.8	$	1.4	$	1.6	$	0.8	$	0.6	$	0.4	$	—
Finance leases(1)		0.2		0.0		0.1		0.1		—		—		—
Water Treatment Services(1)(2)		27.2		2.1		4.1		4.0		3.9		3.8		9.3
Others(3)		9.1		1.9		4.1		3.0		0.1		0.1		—

Large accelerated filer

Accelerated filer

Non-accelerated
filer

Smaller reporting company

Emerging growth company